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          1.1 INTODUCTION 
What is cancer   
The body is made up of billions of tiny cells. Normally, cells grow and multiply 
in a tightly regulated fashion. New cells are only made when and where they 
are needed. When cancer occurs the cells‟ growth cycle goes haywire making 
them multiply uncontrollably. Cells become cancer cells because of damage to 
DNA. This leads to formation of a lump that may be benign or non-cancerous 
or aggressive in its growth.¹ 
Cancer, also called malignancy, is an abnormal growth of cells². It is one of the 
most worldwide spread diseases³. Cancer appears as a mass or ulcerates. Cancer 
is a “great imitator”4. It represents a group of several diseases characterized by 
uncontrolled cell division and growth resulting in tumours, if malignant, may 
spread to other parts of the body. Neoplastic cells originate from differentiated 
and specialized cells through a process of regression and de differentiation to a 
simpler; more primitive stage which divides continuously unlike the normal 
parent cells. The characteristic properties of neoplasia include; sustained 
proliferation, evasion of growth suppressors, immortality, anaplasia , continued 
replication, angiogenesis, reprogramming energy metabolism, invasion, 
metastasis, and escaping immune destruction
5. 
The multistep process including initiation, promotion, and progression of 
carcinogenesis is a complicated process that results from excessive production 
of oxidative radicals, DNA alterations, and lastly the loss of the normal 
regulatory pathways between cell proliferation, differentiation, and apoptosis
6,7
. 
Progress made in cancer therapy has not been sufficient to minimize the annual 
death rates. The currently used conventional anticancer drugs are also toxic to 
normal cells in addition to being toxic to cancer cells
8
. Hence, there is a greater 
need for new effective and safe strategies in cancer control and therapy. 
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Prevention is the most practical strategy to control occurrence and spread of 
cancer. Cancer chemoprevention aims to stop or reverse the development and 
progression of precancerous cells through the use of non-cytotoxic nutrients 
and/or pharmacologically active agents. It is also important to provide various 
cancer chemopreventive natural agents with different specific molecular and 
cellular targets, which act through multiple mechanisms
9
.  
Metastasis: 
Cancer can spread from its original site by local spread, lymphatic spread to 
regional lymph nodes or by haematogenous spread via the blood to distant sites, 
known as metastasis. When cancer spreads by a haematogenous route, it usually 
spreads all over the body. However, cancer 'seeds' grow in certain selected site 
only ('soil') as hypothesized in the soil and seed hypothesis of cancer 
metastasis
4
. 
 
1.2 Causes for Cancer: 
Genetic Mutations (90-95%) 
Inherited genetics (5-10%) 
Chemicals- Tobacco, Alcohol, Smoking (25-30%) 
Diet & exercise (30-35%) 
Infection (15-20%) 
Radiation (10%) 
Heredity 
Physical agents 
Hormones 
Autoimmune diseases 
 
1.3 Cancer Pathophysiology 
There are trillions of cells in the body. These cells have a tightly regulated cell 
cycle that controls their growth, maturity, division and death. During childhood 
normal cells divide faster to allow the person to grow. Once adulthood is 
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reached the cells divide to replace cells and to repair injuries. This cell division 
and growth is controlled by the cellular blue print or DNA and genes that lie 
within the cell‟s nucleus. 
Cancer begins when cells in a part of the body start to grow out of control. All 
types of cancer, irrespective of their origin, occur due to this disturbed growth 
of cells that leads to formation of tumours and lesions. In addition, the cancer 
cells possess some rogue like properties: 
 They have longer life spans and instead of dying continue to grow and form 
new, abnormal cells 
 Cancer cells can also invade other tissues. This is something that normal cells 
cannot do. This property is called metastasis. 
 Cancer cells grow into tumors that are supplied by a new network of blood 
vessels. This is called angiogenesis and is unique in maintaining the blood 
supply and supply of nutrients to the cancer cells
1
. 
 
1.4 Epidemiology of cancer:  
The epidemiology of cancer is the study of the factors affecting cancer, as a way to 
infer possible trends and causes. The study of cancer epidemiology uses 
epidemiological methods to find the cause of cancer and to identify and develop 
improved treatments
11
. 
 
Rates and mortality 
India: 
According to the National Cancer Registry Programme of the India Council of 
Medical Research (ICMR), more than 1300 Indians die every day due to cancer. 
Between 2012 and 2014, the mortality rate due to cancer increased by approximately 
6%. In 2012, there are 4,78,180 deaths out of 2934,314 cases reported. In 2013 there 
are 465,169 death out of 3016,628 cases. In 2014, 491,598 people died in 2014 out of 
2820,179 cases
12
. As per Population Cancer Registry of Indian Council of Medical 
Research, the incidence and mortality of cancer is highest in the North Eastern region 
 Evaluation Of ASVERADO For Its Anti-Neoplastic Activity Against 7,12- Dimethyl 
benz[a]anthracene (DMBA) Induced Mammary Gland Carcinoma In Female Wistar Rats 
4 
  
 
 
  
of the country
13
. Breast cancer is the most common one, with Stomach cancer the 
leading cause of death by cancer for the population as a whole. Breast cancer and 
Lung cancer kill the most women and men respectively
14
. 
 
 
 
 
Most common cancers males, by occurrence
15 
 
 
 
 
                  In females, by occurrence
15 
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Male 
 
Female 
most common (by 
occurrence) 
15 
most common 
(by mortality) 
15 
most common (by 
occurrence) 
15 
most common 
(by mortality) 
15 
prostate cancer (25%) lung cancer (31%) breast cancer (26%) 
lung cancer 
(26%) 
lung cancer (15%) 
prostate cancer 
(10%) 
lung cancer (14%) 
breast cancer 
(15%) 
colorectal 
cancer (10%) 
colorectal cancer 
(8%) 
colorectal cancer 
(10%) 
colorectal 
cancer (9%) 
bladder cancer (7%) 
pancreatic 
cancer (6%) 
endometrial 
cancer (7%) 
pancreatic 
cancer (6%) 
non-Hodgkin 
lymphoma(5%) 
liver & 
intrahepatic bile 
duct (4%) 
non-Hodgkin 
lymphoma(4%) 
ovarian 
cancer (6%) 
skin melanoma (5%) leukemia (4%) thyroid cancer (4%) 
non-Hodgkin 
lymphoma (3%) 
kidney cancer (4%) 
esophageal 
cancer (4%) 
Skin melanoma (4%) leukemia (3%) 
oral and pharyngeal 
cancer(3%) 
bladder 
cancer (3%) 
ovarian cancer (3%) 
uterine 
cancer (3%) 
leukemia (3%) 
non-Hodgkin 
kidney cancer (3%) liver & 
intrahepatic bile 
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lymphoma(3%) duct (2%) 
pancreatic 
cancer (3%) 
kidney 
cancer (3%) 
leukemia (3%) 
brain and other 
nervous system 
(2%) 
other (20%) other (24%) other (22%) other (25%) 
 
 
       
Children: 
Childhood cancer and cancer in adolescents is rare (about 150 cases per million 
yearly in the US). Leukemia (usually acute lymphoblastic leukemia) is the most 
common cancer in children aged 1–14 in the U.S., followed by the central nervous 
system cancers, neuroblastoma, Wilms' tumor, and non-Hodgkin's lymphoma
15
. 
Statistics from the SEER program of the US NCI demonstrate that childhood cancers 
increased 19% between 1975 and 1990, mainly due to an increased incidence in acute 
leukemia. Since 1990, incidence rates have decreased
16. 
 
Infants: 
Neuroblastoma comprised 28% of infant cancer cases and was the most common 
malignancy among these young children (65 per million infants)
16
. 
The leukemias as a group (41 per million infants) represented the next most common 
type of cancer, comprising 17% of all cases
16
. 
Central nervous system malignancies comprised 13% of infant cancer, with an 
average annual incidence rate of nearly 30 per million infants
16
. 
The average annual incidence rates for malignant germ cell and malignant soft tissue 
tumors were essentially the same at 15 per million infants. Each comprised about 6% 
of infant cancer
16
. 
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What makes a normal cell turn cancerous: 
A normal cell can become a cancer cell if it undergoes damage to the DNA. 
Since it is the DNA that regulates the cells‟ cycle of growth and death and any 
changes or damage to DNA affects the cell. 
For most cells if the DNA is damaged the cell either repairs the damage or the 
cell dies. In cancer cells, the damaged DNA is not repaired and the damage is 
propagated to newer abnormal cells that are born of the defective cell. 
Damaged DNA by mutation can also be inherited from parents or relatives. 
DNA damage can also occur due to exposure to toxins like cigarette smoking, 
alcohol etc. 
Normal cell transform into a cancer cells when Gene regulate cell growth and 
differentiation is altered
1
.  
The affected genes are divided into two broad categories. 
 Oncogenes 
Oncogenes are genes that promote cell growth and reproduction. 
 Tumor suppressor gene 
Tumor suppressor genes are genes that inhibit cell division and survival
17
. 
 
Genetic changes can occur at different levels and by different mechanisms. The gain 
or loss of an entire chromosome can occur through errors in mitosis. More common 
are mutations, which are changes in the nucleotide sequence of genomic DNA
18
. 
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1.5 Types of cancers
19
: 
There are more than 200 types of cancers.  
But most common types of cancers are as follows: 
 
Breast cancer: 
A cancer that forms in the cells of the breasts. 
 
Prostate cancer: 
A cancer in a man's prostate, a small walnut-sized gland that produces seminal 
fluid. 
 
Basal cell cancer: 
A type of skin cancer that begins in the basal cells. 
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Melanoma: 
The most serious type of skin cancer. 
 
Colon cancer: 
A cancer of the colon or rectum, located at the digestive tract's lower end. 
 
Lung cancer: 
A cancer that begins in the lungs and most often occurs in people who smoke. 
 
Leukemia: 
A cancer of blood-forming tissues, hindering the body's ability to fight 
infection. 
 
Lymphoma: 
A cancer of the lymphatic system. 
 
Oral Cancer: 
Cancer that develops in any part of the mouth 
 
Cervix Cancer: 
Cancer that develops in the cervix part. 
 
1.6 Signs & Symptoms: 
 
Symptoms vary widely or they may not occur at all. Some patients have 
abnormal bumps, unexplained fevers, night sweats or unintentional weight loss, 
fatigue, pain, skin changes, change in bowel or bladder function, unusual 
bleeding, persistent cough or voice change, lumps, or tissue masses, hair loss
20, 
21
. 
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1.7 Management: 
 
Line of treatment of cancer includes chemotherapy, radiotherapy as well as 
surgery. Patient survival rate depends upon the type, location and stage of the 
disease condition at the onset of treatment. Chemotherapy along with surgery 
has been quite successful in a number of different types of cancer including 
breast, pancreatic, colorectal, osteogenic sarcoma, ovarian, testicular as well as 
certain lung cancers. However, effectiveness of chemotherapy is often limited 
by the toxicity on other non-target tissues. Therefore, complementary and 
alternative safer therapies such as herbal therapies are becoming increasingly 
more popular
22
. 
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2.1 What is breast cancer 
 
Breast cancer is a malignant tumor that starts in the cells of the breast. A 
malignant tumor is capable of invading surrounding tissues or spreading or 
metastasizing to distant areas of the body. The disease occurs almost entirely in 
women, but men can get it, too
23, 24
.  
Breast cancer is the most common malignant disease and the leading cause of 
cancer-related death in women around the world. Worldwide, it is estimated 
that >1 million women are diagnosed with breast cancer every year, and that 
>40% of these patients die from the disease, representing 14% of female cancer 
deaths
23, 25
. 
In the United States, breast cancer is the second leading cause of cancer death 
among women. The American Cancer Society has estimated that 89% of 
women survive 5 years after invasive breast cancer diagnosis
5, 4
.   
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Endocrine therapy targets estrogen receptor-positive breast cancers and 
represents the most effective treatment for them. In the last four decades, 
several hormonal agents have been used in palliative settings for advanced 
cancer and as adjuvant therapy to prevent the recurrence. However, there are 
several proposed molecular mechanisms that explain endocrine resistance in a 
large proportion of patients, which limit the effectiveness of endocrine 
treatments
28, 29,30 
. 
Breast cancer patients with the same stage of disease can have markedly 
different responses and overall outcome. The strongest predictors for metastases 
(for example, lymph node status and histological grade) fail to classify 
accurately breast tumours according to their clinical behaviour
31
. Chemotherapy 
or hormonal therapy reduces the risk of distant metastases by approximately 
one-third; however, 70–80% of patients receiving this treatment would have 
survived without it. None of the signatures of breast cancer gene expression 
reported to date, allow for patient-tailored therapy strategies
32
.  
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Mutations in the p53 gene are associated with a wide variety of human tumors, 
including those of the breast. To assess functionally the role of the p53 gene in 
the development of human breast cancer
33
. 
Breast cancer occurs when a malignant (cancerous) tumor originates in the 
breast. As breast cancer tumors mature, they may metastasize (spread) to other 
parts of the body. The primary route of metastasis is the lymphatic system 
which, ironically enough, is also the body's primary system for producing and 
transporting white blood cells and other cancer-fighting immune system cells 
throughout the body. Metastasized cancer cells that aren't destroyed by the 
lymphatic system's white blood cells move through the lymphatic vessels and 
settle in remote body locations, forming new tumors and perpetuating the 
disease process. 
 
Breast cancer is fairly common. Because of its well-publicized nature, and 
potential for lethality, breast cancer is arguably the most frightening type of 
cancer diagnosis someone can receive. However, it is important to keep in mind 
that, if identified and properly treated while still in its early stages, breast cancer 
can be cured. 
Breast cancer is not just a woman's disease. It is quite possible for men to get 
breast cancer, although it occurs less frequently in men than in women
34
.  
 
2.2 Types of breast cancer: 
There are several varieties of breast cancer. These can affect various parts of the 
breast. Breast cancer is often divided into non-invasive and invasive types. 
Non-invasive breast cancer: 
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Non-invasive breast cancer is also known as cancer or carcinoma in situ, or pre-
cancerous cells. This is seen in the ducts of the breast and does not have the 
ability to spread outside the breast. This form of cancer rarely shows as a lump 
in the breast and is usually found on a routine check up with a mammogram. 
The most common type of non-invasive cancer is ductal carcinoma in situ 
(DCIS)
35, 36
. DICS is classified as Stage 0
37. 
It is the most common type of pre-
cancer in women
38
. 
  
 
 
Invasive cancer: 
 
 
Invasive cancer is more aggressive and spreads outside the breast. The most 
common form of breast cancer is invasive ductal breast cancer. This type 
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develops around the ducts of the breast and accounts for about 80% of all cases 
of breast cancer and is sometimes called 'no special type'
35
. 
Other types of breast cancer 
Less common varieties of breast cancer include invasive lobular breast cancer 
(5-10%),
39,40
 inflammatory breast cancer
41
 and Paget‟s disease of the breast42. 
                                                                         
Types of Breast cancer
 43 
 
 
2.3 Breast Cancer Pathophysiology: 
 
Breast cancer is a malignant tumor that starts in the cells of the breast. Like 
other cancers, there are several factors that can raise the risk of getting breast 
cancer. Damage to the DNA and genetic mutations can lead to breast cancer 
have been experimentally linked to estrogen exposure. Some individuals inherit 
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defects in the DNA and genes like the BRCA1, BRCA2 and P53 among others. 
Those with a family history of ovarian or breast cancer thus are at an increased 
risk of breast cancer
44, 45, 46
. 
The immune system normally seeks out cancer cells and cells with damaged 
DNA and destroys them. Breast cancer may be a result of failure of such an 
effective immune defence and surveillance. 
These are several signalling systems of growth factors and other mediators that 
interact between stromal cells and epithelial cells. Disrupting these may lead to 
breast cancer as well
47, 48
. 
 
 
Breast Cancer Pathophysiology
49 
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2.4 Breast Cancer Epidemiology: 
Breast cancer is the most common cancer in women worldwide after skin 
cancer
50
. It represents 16% of all cancers in women. This rate is twice that 
of colorectal cancer and cervical cancer and about three times that of lung 
cancer. Death rates are also 25% greater than that of lung cancer in women
51, 52
. 
 
Incidence of breast cancer in India: 
Over 100,000 breast cancer patients are estimated to be diagnosed annually in 
India
53
. 
 
Incidence of breast cancer around the world 
All around the world the incidence of this cancer shows varied rates. The rates 
are low in less-developed countries and greatest in the more-developed 
countries. Breast cancer is related to age with only 5% of all breast cancers 
occur in women under 40 years old
54
. 
In the twelve world regions, the annual age-standardized incidence rates per 
100,000 women are as follows
53
: 
 Eastern Asia – 18 per 100,000 women 
 South Central Asia - 22 per 100,000 women 
 Sub-Saharan Africa – 22 per 100,000 women 
 South-Eastern Asia – 26 per 100,000 women 
 North Africa - 28 per 100,000 women 
 Western Asia - 28 per 100,000 women 
 South and Central America - 42 per 100,000 women 
 Eastern Europe - 49 per 100,000 women 
 Southern Europe - 56 per 100,000 women 
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 Northern Europe - 73 per 100,000 women 
 Oceania - 74 per 100,000 women 
 Western Europe - 78 per 100,000 women 
 North America - 90 per 100,000 women 
2.5 Epidemiology of Breast Cancer:  
Worldwide, breast cancer is the most common invasive cancer in women. (The most 
common form of cancer is non-invasive non-melanoma skin cancer; non-invasive 
cancers are generally easily cured, cause very few deaths, and are routinely excluded 
from cancer statistics.) Breast cancer comprises 22.9% of invasive cancers in women 
and 16% of all female cancers
55, 56
. 
In 2008, breast cancer caused 458,503 deaths worldwide (13.7% of cancer deaths in 
women and 6.0% of all cancer deaths for men and women together). Lung cancer, the 
second most common cause of cancer-related death in women, caused 12.8% of 
cancer deaths in women (18.2% of all cancer deaths for men and women together)
55 
By age group: 
Breast cancer is strongly related to age, with only 5% of all breast cancers occurring 
in women under 40 years old
57
. 
By region: 
The incidence of breast cancer varies greatly around the world: it is lowest in less-
developed countries and greatest in the more-developed countries. In the twelve 
world regions, the annual age-standardized incidence rates per 100,000 women are as 
follows: in Eastern Asia, 18; South Central Asia, 22; sub-Saharan Africa, 22; South-
Eastern Asia, 26; North Africa and Western Asia, 28; South and Central America, 42; 
Eastern Europe, 49; Southern Europe, 56; Northern Europe, 73; Oceania, 74; Western 
Europe, 78; and in North America, 90
58 
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                  Cancer occurrence in females
59 
 
 
             Cancer occurrence in women
59 
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2.5 Causes for Breast Cancer:
 
 
The causes of breast cancer are not yet definitively known. However, extensive 
research efforts have uncovered various risk factors that are associated with 
increased incidence of breast cancer in women. Though some of these risk 
factors are unavoidable and uncontrollable, some of them are very avoidable, 
making it possible for people to take action so as to minimize their cancer risk. 
Even a minimized risk is still a risk, however. There is no way to pre-determine 
whether a person will get breast cancer until they have either been diagnosed 
with it or they have lived a breast-cancer free lifetime
60,61
. 
Some of the risk factors for breast cancer that are difficult or impossible to 
control include: 
 Age:  As women age their chance of getting breast cancer increase. The 
majority of breast cancer cases are diagnosed in women over the age of 50
62
. 
 Family and genetic history: Some cases of breast cancer are known to have 
been caused as a result of genetic mutation. Gene mutations can be inherited 
from parents and can also occur in otherwise healthy people in response to 
environmental toxins. Having a close relative on either side of your family who 
has breast cancer will, in general, increase your risk of contracting breast 
cancer.  This is particularly true if the relative is what is called "first degree" 
meaning your sister or mother.  In general, the more first degree relatives that 
have had breast cancer the more likely you are to develop breast cancer as 
well
63
. 
 
 BRCA gene mutation.  Recent advances in genetic mapping have discovered 
a gene mutation that increases the risk of certain female cancers in women with 
the mutation.  The two main breast and ovarian cancer susceptibility genes are 
known as BRCA1 and BRCA2
64
. 
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 Previous breast cancer. A woman who previously had breast cancer and has 
been cured has a greater chance for having a new breast cancer episode occur 
than is a woman who never had the disease. New tumors appearing inside 
someone with a previous history of cancer who has been cancer free are not 
necessarily related to or caused by old eradicated tumors. Instead, new tumors 
can form spontaneously in vulnerable persons
65
. 
 
 Race. Hispanic and Asian women have lower risk for getting breast cancer 
than do Caucasian and African American women. In fact, Caucasian women are 
at the highest risk of getting the disease compared to women of other racial 
backgrounds. . It may occur because, as a group, these women have less access 
to healthcare, or possibly because they are less likely as a group to seek 
healthcare.  Research is ongoing in this area to determine the cause of this 
alarming disparity
62
. 
 
 Previous benign tumor biopsy results. Women who have had previous 
biopsy that has found a benign (non-cancerous) tumor in the breast are at a 
greater risk for malignant breast tumors in the future. However, the occurrence 
of cysts in the breast does not increase the risk for future breast cancer
65
. 
 
 Prior radiation treatment in the chest area. Women who receive prior 
radiation treatment directed at their chest area for any reason are at a heightened 
risk for future breast cancer compared to women who do not receive radiation 
treatment. The earlier in life women are exposed to chest-targeted radiation 
treatment, the higher their later risk for breast cancer. Radiation exposure from 
various sources including medical treatment and nuclear explosion increases the 
risk of breast cancer
65
.  
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 Menstrual Cycles. Women who begin menopause after the age of 50 or who 
had their first menstrual cycle before age 12 run a slightly higher risk for breast 
cancer than women whose menstrual cycles started after age 12 and end prior to 
age 50.  This is due to prolonged exposure to high levels of certain reproductive 
hormones
66
. 
 
While the above risk factors for breast cancer are difficult or impossible to 
avoid, there are also numerous risk factors for breast cancer that can be avoided 
by making healthy lifestyle choices. While choosing a healthy lifestyle may not 
always be simple or easy, making such lifestyle changes can help you lower 
your cancer risk with regard to the following risk factors 
 
 Use of Birth Control Pills. Some studies have shown that women who use 
birth control pills are at a slightly increased risk for breast cancer. However, any 
relationship between breast cancer and birth control pill use remains 
controversial at this time, pending further research. It's not all bad news. While 
oral contraceptives (birth control pills) may slightly increase risk of breast 
cancer
67
. 
 
 Not Having Children. Women who have their first child after the age of 30 
or who have never had children run a slightly higher risk for contracting breast 
cancer than do women who give birth before reaching age 30. This is again due 
to more prolonged exposure to reproductive hormones
68
.  
 
 Hormone Replacement Therapy. Hormone replacement therapy (HRT) is 
sometimes prescribed to women as a means of alleviating discomfort associated 
with menopause. Research indicates that women who have received HRT for 
five years or more may be at a heightened risk for breast cancer. However, the 
heightened risk seems to occur primarily in women using combined (estrogen 
and progesterone mixture) HRT, as opposed to estrogen-only HRT. However, 
estrogen-only HRT increases risk of uterine cancer. The elevated breast cancer 
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risk appears to be reversible in that women who discontinued HRT for five or 
more years show no more increased risk for breast cancer than women who 
never used it in the first place. There are real benefits to HRT that should not be 
dismissed lightly just because of the elevated breast cancer risk it may come 
with. Talk to your doctor about your risks and benefits with regard to HRT. 
HRT may be a good idea for you if you are at a low risk for breast cancer and 
could benefit from its therapeutic effects. However, if you are already at a high 
risk for breast cancer you should carefully weigh the risks and benefits before 
beginning HRT
69,70
. 
 
 Failing To Exercise. Some recent studies have found a small relationship 
between moderate exercise and decreased risk of breast cancer. Exercising 
regularly can help combat obesity as well which further lowers cancer risk
71
. 
 Breast Feeding. Multiple studies have demonstrated that breast feeding is 
associated with reduced risk of breast cancer. In addition, the longer you breast 
feed the better the cancer protection you appear to achieve
72
. 
 
 Excessive Alcohol Intake. Drinking alcohol has been shown to slightly 
increase the risk of breast cancer
65
. 
 
 Obesity and Poor Diet. Research has established a link between being 
overweight and an elevated risk of postmenopausal breast cancer. This seems to 
be because the majority of reproductive hormones in postmenopausal women is 
produced in the fat cells.  Therefore, the more fat cells a woman has the higher 
their reproductive hormone levels
73
. 
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 Exposure to Diethylstilbesterol (DES): Women who took diethylstilbestrol 
(DES) to prevent miscarriage may have an increased of breast cancer after age 
40
74
. 
 
2.6 Sign & Symptoms of Breast Cancer
75, 76, 77 
: 
Breast cancer is a disease that progresses in stages, building in intensity over 
time. The early stages of breast cancer there may be no discernable symptoms. 
Early breast cancers may be asymptomatic, and pain and discomfort are 
typically not present. If a lump is discovered, the following may indicate the 
possible presence of breast cancer. 
During the early and middle stages of breast cancer symptoms can include the 
following: 
 A lump, dimple or thickening in the breast 
 A lump or swelling in the armpit (an enlarged lymph node) 
 Change in the shape of the breast 
 Change in the size of the breast, including swelling 
 Change in the color or texture of the breast and/or nipple, including redness, 
scaly, dimpled, retracted, or puckered appearance 
 Breast pain, especially if in one breast only 
 Abnormal discharge from the nipple. 
 
Diagnosis: 
Breast cancer is often first detected as an abnormality on a mammogram before 
it is felt by the patient or health care provider. 
Evaluation of breast cancer includes the following: 
 Clinical examination 
 Imaging 
 Needle biopsy 
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Physical examination 
The following physical findings should raise concern: 
 Lump or contour change 
 Skin tethering 
 Nipple inversion 
 Dilated veins 
 Ulceration 
 Paget disease 
 Edema or peau d‟orange 
If a palpable lump is found and possesses any of the following features, breast 
cancer may be present: 
 Hardness 
 Irregularity 
 Focal nodularity 
 Fixation to skin or muscle 
 
Screening 
Early detection remains the primary defense in preventing breast cancer. 
Screening modalities include the following: 
 Breast self-examination 
 Clinical breast examination 
 Mammography 
 Ultrasonography 
 Magnetic resonance imaging 
 
Ultrasonography and MRI are more sensitive than mammography for invasive 
cancer in nonfatty breasts. Combined mammography, clinical examination, and 
MRI are more sensitive than any other individual test or combination of tests. 
 
Biopsy 
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Core biopsy with image guidance is the recommended diagnostic approach for 
newly diagnosed breast cancers. This is a method for obtaining breast tissue 
without surgery and can eliminate the need for additional surgeries. Open 
excisional biopsy is the surgical removal of the entire lump. 
 
2.7 Screening of Breast cancer: 
There are several methods to screen breast cancer. 
 Clinical Breast Exam. During a clinical breast exam (CBE for short) a doctor 
first observe your breasts for any inequalities or changes in size or shape, then 
palpates (feels) your breasts and armpits looking for lumps and swellings
78
. 
 
 Mammogram. A mammogram is basically an x-ray image of the breast's 
interior tissues and any lumps or irregularities that may exist therein. During 
this procedure breast is placed between two plates which are then slightly 
compressed. Your breast is then subject to a beam of radiation and an x-ray 
picture is taken
79
. 
 
 Axillary Dissection and Biopsy.  An axillary dissection involves a small 
surgery wherein cells from the lymph nodes in the armpit are removed and then 
studied under the microscope to determine if they are cancerous. The general 
name for this tissue sampling and study is "biopsy"
79
. 
 
 Hormone receptor testing. Recent advances in testing of biopsy specimens 
allow doctors to test tumor samples for certain hormone receptors. If these 
hormone receptors are present in the tumor it allows doctors to use certain 
medications to help fight the cancer and can improve a person's likelihood of 
survival
80
. 
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2.8 Treatment for Breast Cancer:  
There are two general approaches to treating cancers: local treatment and 
systemic (whole body) treatment. 
 
Local treatment involves treating just the small areas of the body containing 
tumors while affecting the rest of the body as little as possible. 
 
Systemic treatment approaches, on the other hand, are used to treat cancer that 
has spread throughout the body. 
      
Local treatment approaches alone may be all that is required for treatment of 
early stage breast cancer (e.g., before metastasis - the spreading of cancerous 
tissues through the body -- has occurred). 
 
Combined local and systemic approaches may be necessary for treatment of 
more advanced cancers. Surgical approaches tend to fall into the local treatment 
category, while chemotherapy approaches fall into the systemic category. 
 
Radiation therapy approaches can be local or systemic depending on how they 
are administered. 
 
The majority of women who are afflicted by breast cancer will require some 
type of surgery. The goal of the surgical procedure is to remove the cancerous 
tumor while preserving as much of the healthy breast tissue as possible. Later 
stage breast cancers often require more extensive surgeries as more tissues get 
involved in the disease process
81
. 
 
Some of the surgical procedures used to treat breast cancer are: 
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 Lumpectomy. Lumpectomy is a surgical procedure in which the breast tumor 
is removed while sparing as much healthy surrounding tissue as possible. The 
benefit of lumpectomy is that in most circumstances the mass and form of the 
breast can be retained. Radiation treatment and chemotherapy are often given in 
conjunction with lumpectomy. Recovery time from a lumpectomy is very 
short
82
. 
 
 Partial Mastectomy. This surgical procedure is similar in principle to a 
lumpectomy but involves removing more of the tissue surrounding the 
cancerous tumor. Partial mastectomy can also be followed by radiation therapy 
or chemotherapy
83
. 
 
 
 Modified Radical Mastectomy. This surgical procedure involves removing 
the entire breast mass and involved lymph nodes from under the arm (while 
preserving as many of the lymph nodes as possible). Understandably, removal 
of the entire breast and the disfigurement this creates can be traumatic and 
depressing for many women. Reconstructive surgery may be desirable
83
. 
 
 Radical Mastectomy. During this surgical procedure the entire breast is 
removed as well as the lymph nodes under the arm and the pectoral (chest) 
muscles under the breast
84
. 
 
Surgical removal of the tumor causing a cancer is often not sufficient for a full 
recovery, particularly when metastasis has occurred. It is common to see 
systemic chemotherapy or radiation therapies applied in conjunction with 
surgery. Chemotherapy and radiation therapies offer doctors a way to destroy 
any cancer cells in the surrounding area of the main tumor that they might have 
missed during surgery. 
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 Hormonal therapy. Tumor biopsy specimens can be tested for specific 
hormone receptors it has allowed scientists to develop drugs which can block 
those receptors and slow a tumor's growth. The main type of drug used blocks 
the effects of a hormone called estrogen
80
. 
 
2.9 Management: 
Surgery and radiation therapy, along with adjuvant hormone or chemotherapy 
when indicated, are now considered primary treatment for breast cancer. 
Surgical therapy may consist of lumpectomy or total mastectomy. Radiation 
therapy may follow surgery in an effort to eradicate residual disease while 
reducing recurrence rates. There are 2 general approaches for delivering 
radiation therapy: 
 External-beam radiotherapy (EBRT) 
 Partial-breast irradiation (PBI) 
Surgical resection with or without radiation is the standard treatment for ductal 
carcinoma in situ
85, 86
. 
Pharmacologic agents 
Hormone therapy and chemotherapy are the 2 main interventions for treating 
metastatic breast cancer. Common chemotherapeutic regimens include the 
following: 
 Docetaxel 
 Cyclophosphamide 
 Doxorubicin 
 Carboplatin 
 Methotrexate 
 Trastuzumab 
Two selective estrogen receptor modulators (SERMs), tamoxifen and 
raloxifene, are approved for reduction of breast cancer risk in high-risk women. 
HER2-targeted therapies have been investigated in combination with 
angiogenesis inhibitors, with promising results. HER2 overexpression is 
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associated with an increase in VEGF levels in primary breast cancers. Dual 
blockade by antiangiogenic/HER2 agents (eg, neratinib) targeting HER2, and 
EGFR pathways produces greater inhibition of human breast cancer cell lines. 
In patients receiving adjuvant aromatase inhibitor therapy for breast cancer who 
are at high risk for fracture, the monoclonal antibody denosumab or either of 
the bisphosphonates zoledronic acid and pamidronate may be added to the 
treatment regimen to increase bone mass. These agents are given along with 
calcium and vitamin D supplementation
87
. 
 
2.10 Herbs as alternatives to anticancer therapy
88
: 
 
The use of herbs as anticancer botanicals has been in practice since ancient 
times that began with folk medicine and by the time has been adopted in 
traditional and allopathic medicine. Many drugs currently used in chemotherapy 
were either isolated from plant species or derived from their natural precursors. 
Vincristine and vinblastine (Vinca alkaloids) isolated from Catharanthus 
roseus; semisynthetic derivatives of podophyllotoxin viz. etoposide and 
teniposide, derived from Podophyllum spp.; taxanes isolated from Taxus spp., 
camptothecin, irinotecan and topotecan, from Camptotheca acuminata, and 
many others are few examples. According to a study, over 50 % of the 
anticancer drugs in clinical trials are directly or indirectly derived from plants. 
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Plant-derived drugs 
Anticancer 
agent 
Isolated or derived from: Compound 
activity 
Sulphoraphane Isotiocynanate in 
cruciferous 
vegetables Brassica 
Induces phase 2 
detoxification 
enzymes; inhibits 
tumor growth in 
breast cancers; 
antiproliferate 
effects 
Paclitaxel 
(Taxol) 
Taxane; Taxus brevifoliaL Microtubule 
disruptor; block 
mitosis; induce 
apoptosis; 
microtubules are 
polymerized and 
stabilized; 
disruption of 
spindle formation; 
inhibition of 
translational 
machinery 
Epipodophyllotoxin Podophyllum peltatumL.; 
Podophyllotoxin isomer 
Pro-apoptotic 
effects; cell cycle 
interference 
Vincristine Catharanthus roseus G. Anti-mitotic; 
microtubule 
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Vinblastine 
Don; Vinca alkaloids inhibitor; bind to 
β-tubulin; 
microtubule 
stabilizers or 
destabilizers; pro-
apoptotic 
properties and 
induce cell cycle 
arrest; anti-tumour 
activity 
Vinorelbine 
Vindesine 
Vinflunine 
Pomiferin Isoflavonoid isolatated 
from Maclura pomifera; 
Dereeis Malaccensis 
Pro-apoptotic 
effects; DNA 
fragmentation; 
inhibits oxidative 
damage of DNA; 
antioxidant 
activity; inhibits 
histone 
deacetylases; 
cytotoxicity of 
cancer cells 
Epigallacotechin
-3-gallate 
Catechin; green tea Antioxidant; 
decrease DNA 
damage from 
oxidative stress; 
anti-proliferative 
effects; inhibition 
of specific kinases; 
inhibit 
carcinogenesis 
induced 
chemically or by 
UV 
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Combretastatin 
A-4 phosphate 
Water-soluble analogue of 
combretastatin; Combretu
m caffrum 
Anti-angiogenic; 
vasuclar shut-
down of tumors; 
tumor necrosis 
Roscovitine Derived from 
olomucine; Raphanus 
sativus L. (Brassicaceae) 
Inhibition of cyclin 
dependent kinases; 
reduction of cell 
cycle progression 
Flavopiridol Synthetic flavonoid 
derivative; rohitukine 
based 
structure; Dysoxylum 
binectariferumHook.f. 
(Meliaceae) 
Anti-
inflammatory; 
immunamodulator
y activity; tyrosine 
kinase activyt; 
growth inhibitory 
effects 
Noscapine Opium poppy (Papaver 
somniferum) 
Antiproliferative 
properties; 
microtubule 
interfering; 
inhibits tumour 
growth and 
progression 
 
 
Antioxidants are chemical substances derived from natural sources or from 
synthetic origin, protect the body from oxidative stress either by preventing the 
formation of  ROS or by interfering ROS attack by scavenging the reactive 
intermediates or by converting to less reactive molecules. The antioxidant 
capacity tells about the duration whereas the activity denotes the starting 
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dynamics of antioxidative mechanism. Therefore, uses of antioxidants, both 
natural and synthetic are gaining widespread importance in prevention of 
diseases
89
. 
Many natural products obtained from medicinal plants, or secondary 
metabolites such as alkaloids, terpenoids, phenolic acids, flavonoids, tannins, 
lignins, quinones, coumarins which exhibit potential antioxidant and other 
properties, have played an important role in treatment of cancer. Studies suggest 
that antioxidants possess anti-inflammatory, antimutagenic and anti-
carcinogenic activities. Medicinal plants thus can be very promising in 
improving the present and future health needs against cancer. This is because of 
their secondary metabolites which can maintain the health and cure of various 
diseases including cancer with less harmful effects)
89
.  
 
Eighty percent of world‟s population uses plants to cure disease, so the WHO 
(World Health Organization) recommends the use of medicinal plants in 
primary health care systems but based on scientific evidence to assure the 
safety, effectiveness, and quality required
89
. 
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What are free radicals, and do they play a role in cancer 
development :
88,89 
Free radicals are highly reactive chemicals that have the potential to harm 
cells. They are created when an atom or a molecule (a chemical that has 
two or more atoms) either gains or loses an electron (a small negatively 
charged particle found in atoms). Free radicals are formed naturally in the 
body and play an important role in many normal cellular processes. At 
high concentrations, however, free radicals can be hazardous to the body 
and damage all major components of cells, including DNA, proteins, and 
cell membranes. The damage to cells caused by free radicals, especially 
the damage to DNA, may play a role in the development of cancer and 
other health conditions. 
Abnormally high concentrations of free radicals in the body can be 
caused by exposure to ionizing radiation and other environmental toxins. 
When ionizing radiation hits an atom or a molecule in a cell, an electron 
may be lost, leading to the formation of a free radical. The production of 
abnormally high levels of free radicals is the mechanism by which 
ionizing radiation kills cells. Moreover, some environmental toxins, such 
as cigarette smoke, some metals, and high-oxygen atmospheres, may 
contain large amounts of free radicals or stimulate the body‟s cells to 
produce more free radicals. 
Free radicals that contain the element oxygen are the most common type 
of free radicals produced in living tissue. Another name for them is 
“reactive oxygen species,” or “ROS” 
 
What are antioxidants? 
Antioxidants are chemicals that interact with and neutralize free radicals, 
thus preventing them from causing damage. Antioxidants are also known 
as “free radical scavengers.” 
The body makes some of the antioxidants it uses to neutralize free 
radicals. These antioxidants are called endogenous antioxidants. 
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However, the body relies on external (exogenous) sources, primarily the 
diet, to obtain the rest of the antioxidants it needs. These exogenous 
antioxidants are commonly called dietary antioxidants. Fruits, vegetables, 
and grains are rich sources of dietary antioxidants. Some dietary 
antioxidants are also available as dietary supplements. 
Examples of dietary antioxidants include beta-carotene, lycopene, and 
vitamins A, C, and E (alpha-tocopherol). The mineral element selenium 
is often thought to be a dietary antioxidant, but the antioxidant effects of 
selenium are most likely due to the antioxidant activity of proteins that 
have this element as an essential component (i.e., selenium-containing 
proteins), and not to selenium itself . 
 
Can antioxidant supplements help prevent cancer? 
In laboratory and animal studies, the presence of increased levels of 
exogenous antioxidants has been shown to prevent the types of free 
radical damage that have been associated with cancer development.  
 
Antioxidant supplementation and cancer prevention: 
 
Experimental 
Intervention 
Sampl
e Size 
Duration Of 
Study 
Characteristics 
Of Participants 
Study Outcome 
B-
carotene: 15mg/day 
Vit E: 30mg/day 
Selenium: 
50mcg/day 
29,584 6 years 
Malnourished Age: 
40 - 69 
Lower cancer rate 
B-carotene: 
20mg/day 
compared to 
atocopherol: 50mg/
29,133 
5 - 8 years 
Average 6 yea
rs 
Male smokers Age: 
50 - 69 
B-carotene: 
20mg/day 
associated with 
increase in lung 
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day cancer 
B-
carotene: 30mg/day 
and  
retinyl palmitate: 25 
000IU/day 
18,314 4 years 
Male and female 
Age: 45 - 74 
Smoker and/or 
occupational expos
ure to asbestos 
No clear evidence  
of benefit. Associat
ed with more death 
B-carotene: 50mg 
on alternate days 
22,071 
11.6 - 14.2 
years, 
average 12 
years 
Male Age: 40 - 84 
Current/former or n
on-smokers 
No clear 
evidence of benefit 
or harm related to 
cancer risk 
B-carotene: 50mg 
on alternate days  
39,876  
0.00-2.72 
years, median 
2.1 years 
Female Age: > = 
45  
No 
significance differe
nce in incidence 
of cancer 
 B-carotene:  
25mg/day Vit C: 
1000mg/day Vit E: 
400IU/day 
864 4 years 
Adenoma diagnose
d Good health 
Age: < 80 
No clear evidence 
of benefit 
B-carotene:  
50mg/day  
1,805 
5 years 
Recent non-
melanoma skin 
cancer 
 No clear evidence 
of benefit 
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Piper aduncum Capsule on DMBA-induced Breast Cancer in Rats  
Arroyo-Acevedo J et al, investigated that the protective effect of Piper 
aduncum capsule on DMBA (dimethylbenz[α]anthracene)-induced breast cancer in 
rats. It was assessed by monitoring the tumor and lung metastases incidence and 
recording hematological and biochemical parameters. There was a significant 
decrease in the frequency of DMBA-induced micronucleated polychromatic 
erythrocyte (P < 0.01). Considering the antitumorigenic, hypolipidemic, anti-
inflammatory, antioxidant, and antigenotoxic properties of P. aduncum capsule.  
 
Breast Cancer (Auckl). 2015 Jun 29;9:41-8. doi: 10.4137/BCBCR.S24420. 
 
Ulva lactuca polysaccharides prevent Wistar rat breast carcinogenesis 
Gamal-Eldein F Abd-Ellatef et al, investigated on the isolation and function of the 
polysaccharides derived from different algal species, which revealed multiple biological 
activities such as antioxidant and antitumor activities by using in vitro bioassays on human 
breast cancer cell line (MCF-7) and an in vivo animal model of breast carcinogenesis. 
Breast Cancer (Dove Med Press). 2017 Feb 27;9:67-83. doi: 10.2147/BCTT.S12516 
 
Mammary Cancer in 7,12-Dimethylbenz(a)anthracene-Induced Wister Rats by 
Asymmetrical Temperature Distribution Analysis  
S. P. Angeline Kirubha et al investigated that animal surface temperature profile 
captured using infrared camera is helpful for the assessment of physiological 
responses associated with the regulation of body temperature. Temperature difference 
between the tumor induced lower right and left side of flank region was significant 
(with P value < 0 . 0 0 1), whereas in the abdomen and shoulder there was no 
significant difference in temperature between right and left sides.. Temperature 
reduction was observed in the tumor induced region after the seventh day of 
carcinogen induction. 
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Volume 2012 (2012), Article ID 786417, 11 pages 
Induction of experimental mammary carcinogenesis in rats with 7,12-
dimethylbenz(a)anthracene 
Alfredo Carlos S. D. Barros et al, investigated that the when 7,12-
dimethylbenz(a)anthracene (DMBA) intragastrically by gavage produces mammary 
gland tumor after the 8 and 13 weeks. At the end of the experiment, the animals were 
sacrificed, and the mammary tumors were measured and weighed. Tumor fragments 
were analyzed using light microscopy. 
Rev. Hosp. Clin. vol.59 no.5 São Paulo  2004 
 
Protective effect of Operculina turpethum against 7,12-dimethyl 
benz(a)anthracene induced to breast cancer in experimental rats. 
Anbuselvam C  et al, investigated  the Reactive oxygen species (ROS) directly or 
indirectly involves in multistage process of carcinogenesis. Antioxidant activity of 
methanolic extract of Operculina turpethum stems (MEOT) on 7,12 
dimethylbenz(a)anthracene (DMBA) induced breast cancer. 
 A significant (P<0.05) increase in the tumour weight was observed in the breast of 
DMBA group and the breast tumour weight decreased significantly (P<0.05) in the 
DMBA+MEOT groups. Oral administration of MEOT remarkably reduced the lipid 
peroxidation activity and increased the antioxidants level in drug treated animals and 
decreased the tumour weight significantly (P<0.05).  
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Chem Biol Interact. 2007 Jul 20;168(3):229-36. Epub 2007 Apr 22. 
 
Cholestyramine promotes 7,12-dimethylbenzanthracene induced mammary 
cancer in Wistar rats. 
M. F. Melhem et al carried out research on the promotion of 7,12-
dimethylbenzanthracene (DMBA) induced mammary cancer in Wistar rats by a 4% 
cholestyramine (CHST) diet. In rats treated with DMBA and fed a 4% CHST diet, the 
incidence of malignant tumours increased by 5 fold, and the tumour weight by 12 
fold. In addition, the serum total lipids, cholesterol esters and triglycerides decreased 
significantly when compared with rats fed a control diet. These results suggest that 
CHST diet promotes DMBA induced mammary cancers in Wistar rats. 
 
Br J Cancer. 1987 Jul; 56(1): 45–48. 
 
Black tea and mammary gland carcinogenesis by 7,12-
dimethylbenz[a]anthracene in rats fed control or high fat diets.  
Rogers AE et al studies suggest that chemopreventive effects of tea or purified 
extracts of tea have been demonstrated in lung, gastrointestinal tract and skin, 
mammary gland. Rats fed the HF diet and given 2% tea showed no increase in tumor 
burden; their tumor burden was significantly lower than in rats fed the HF diet and 
given water (P < 0.01) and was not different from rats fed control diet and given 
water or tea. In addition, in experiment 3, the number of malignant tumors per tumor-
bearing rat was increased by the HF diet in water-drinking rats (P < 0.01) but not in 
tea-drinking rats. Therefore, it appears that tea partially blocked the promotion of 
DMBA-induced mammary tumorigenesis by the HF diet. 
 
Carcinogenesis. 1998 Jul;19(7):1269-73. 
 
Effects of different animal and vegetable fats fed in rats.  
Sylvester PW et al investigated to determine whether diets high in animal or 
vegetable fat affected mammary tumorigenesis when fed to rats only prior to and 
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during the initiation phase of carcinogenesis. In conclusion, high dietary intake of lard 
and beef tallow, but not vegetable fat, fed from weaning until only 1 week after 
DMBA administration, significantly enhances mammary tumorigenesis in rats. 
 
Cancer Res. 1986 Feb;46(2):757-62. 
 
Chemopreventive effect of Annona muricata in the breast tissues of female 
albino mice. 
J.B. Minari et al was aimed at evaluating the potential chemopreventive effect of an 
ethanolic extract of Annona muricata leaves on 7,12-dimethylbenzeneanthracene 
(DMBA)-induced cell proliferation in the breast tissues of female albino mice. This 
study has shown that the leaf extract of A. muricata could be used as a prophylactic 
measure against DMBA-induced cell proliferation in the breast tissues of female 
albino mice.  
 
DOI: 10.1016/j.ejmhg.2014.05.001 
 
Cow ghee versus soybean oil on 7,12-dimethylbenz(a)-anthracene induced 
mammary carcinogenesis & expression of cyclooxygenase-2 & peroxisome 
proliferators. 
Rita Rani et al investigated the effect of feeding cow ghee versus soybean oil on 7,12-
dimethylbenz(a)anthracene (DMBA) induced mammary cancer in rat and expression 
of cyclooxygenase-2 and peroxisome proliferators activated receptor- γ (PPAR-γ) in 
mammary gland. Histological analysis of tumours showed that the progression of 
carcinogenesis was more rapid on soybean oil than on cow ghee. The expression of 
cyclooxygenase-2 was observed only in DMBA treated rats and it was significantly 
less on cow ghee than on soybean oil. The expression of PPAR-γ was significantly 
more on cow ghee than on soybean oil.  The effect is mediated by decreased expression 
of cyclooxygenase-2 and increased expression of PPAR-γ in the former group. 
 
Indian J Med Res. 2011 May; 133(5): 497–503 
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7,12-dimethylbenzanthracene induced mammary tumours in wistar rats by „air 
pouch‟ technique  
B. Arun, et al investigated an „air pouch‟ technique of inducing highly localized, 
transplantable, estrogen-dependent adenocarcinomas of the mammary gland in Wistar 
rats with 7,12-dimethylbenzanthracene (DMBA). Using this model estrogen receptor 
status, transplantation and effect of exogenous hormones on tumour growth have been 
studied. 
December 1984Volume 25, Issue 2, Pages 187–19 
Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth 
by 2,3,7,8-tetrachlorodibenzo-p-dioxin   
M. Holcomb et al carried out a research on 2,3,7,8-Tetrachlorodibenzo-p-dioxin 
(TCDD) and related compounds inhibit diverse estrogen-induced responses in the 
rodent uterus and human breast cancer cells. The effects of a single non-toxic dose of 
TCDD (10 μg/kg) on the development of mammary tumors was investigated in 
female Sprague-Dawley rats, the mean tumor volumes decreased from 89.7 ± 53 
mm3 to 24.9 ± 28.5 mm3. Moreover, these results demonstrate the antitumorigenic 
activity of TCDD in female Sprague-Dawley rats. 
July 15, 1994Volume 82, Issue 1, Pages 43–47 
Enhancement of pro-oxidant effect of 7,12-dimethylbenz (a) anthracene (DMBA) 
in rats by pre-exposure to restraint stress  
Muqbil I et al designed to assess the effect of immobilization stress on liver toxicity 
induced by topical as well as oral administration of 7,12-dimethyl benz(a)anthracene 
(DMBA) in Swiss Albino rats. Biochemical measurements were carried out on liver 
tissues and serum/plasma of control and treated animals. The results of the present 
study indicate that immobilization stress markedly enhances DMBA induced 
alteration of liver and circulatory antioxidant status of the rats irrespective of the 
mode of DMBA administration though with a predominant effect on orally infused 
DMBA. 
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Cancer Lett. 2006 Aug 28;240(2):213-20. Epub 2005 Nov 2. 
 
Experimentally induced mammary tumors in rats  
Jose Russol et al carried out research on the multiple experimental animal models 
employed for analyzing the various aspects of mammary carcinogenesis. Using the 
DMBA rat mammary model, we have been able to demonstrate that the carcinogen 
acts on the intermediate cell of the terminal end bud (TEB), and that this structure is 
the one that evolves to intraductal proliferation, carcinoma in situ, and invasive 
carcinoma. There are several factors that regulate the susceptibility of the TEB; some 
of them are: a) topographic location of the mammary gland, b) age of the animal, and 
c) reproductive history.  
 
Breast Cancer Res Treat. 1996;39(1):7-20.   
 
Suppression of 7,12-Dimethylbenz(α) Anthracene-Induced Breast Carcinoma by 
Coumarin in the Rat    
Feuer G et al carried out a research on the effect of oral administration of coumarin 
on the induction of breast tumors brought about by DMBA has been studied in female 
Wistar rats. Coumarin given after DMBA elicited no effect on the carcinogenic 
potency of DMBA. In contrast to the action on mammary tumorigenesis, coumarin 
provided no protection against hemopoietic and adrenocortical necrosis brought about 
by DMBA. 
 
Oncology 1976;33:35–39 (DOI:10.1159/000225098) 
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Activity of Avocado: 
 
Effect of Semisolid Formulation of Persea Americana Mill (Avocado) Oil on 
Wound Healing in Rats 
Ana Paula de Oliveira et al carried out the study to evaluate the wound-healing 
activity of a semisolid formulation of avocado oil, SSFAO 50%, or avocado oil in 
natura, on incisional and excisional cutaneous wound models in Wistar rats. An 
additional objective was to quantify the fatty acids present in avocado oil. Anti-
inflammatory activity, increase in density of collagen, and tensile strength were 
observed in SSFAO 50% or avocado oil groups. Results show that avocado oil is a 
rich source of oleic acid and contains essential fatty acids, avocado oil can promote 
increased collagen synthesis and decreased numbers of inflammatory cells during the 
wound-healing process. 
 
Evid Based Complement Alternat Med. 2013; 2013: 472382 
 
Inhibition of prostate cancer cell growth by an avocado extract 
Qing-Yi Lu et al carried out an research on acetone extract of avocado containing 
these 
carotenoids and tocopherols was shown to inhibit the growth of both androgen-
dependent (LNCaP) and androgen-independent (PC-3) prostate cancer cell lines in 
vitro. Incubation of PC-3 cells with the avocado extract led to G2/M cell cycle arrest 
accompanied by an increase in p27 protein expression. Lutein alone did not reproduce 
the effects of the avocado extract on cancer cell proliferation.. 
 
Journal of Nutritional Biochemistry 16 (2005) 23 – 30 
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Apoptosis of human oral cancer cell lines by avocado extracts via a ROS-
mediated mechanism. 
 Ding H, et al investigated that avocados have a high content of phytochemicals with 
potential chemo preventive activity. The phytochemicals extracted from avocado 
induced apoptosis in cancer but not normal, human oral epithelial cell lines. In this 
study treatment of human oral cancer cell lines containing high levels of reactive 
oxygen (ROS) with D003 increased ROS levels twofold to threefold and induced 
apoptosis. 
 
2009;61(3):348-56.  
 
Effect of the Water Extracts of Avocado Fruit and Cherimoya Leaf on Human 
Cancer Cell Lines and Vicia Faba Root Tip Cells 
Noha S. Khalifa et al investigated the effect of the water extract of Persea americana 
Mill. (avocado fruit) and Annona cherimolia Mill (cherimoya leaf) on living cells. 
The antiproliferative properties of avocado fruit water extract (AFWE) and cherimoya 
leaf water extract (CLWE) were determined using four human cancer cell lines: lung 
(A549), liver (HepG-2), colon (HT-29) and breast (MCF-7). The prophase cell 
percentage was linearly increasing with the applied concentration without 
micronuclei formation in avocado treatment. Results indicate that avocado and 
cherimoya extracts were highly cytotoxic and mitodepressive on cancer and plant 
cells. 
 
Journal of Agricultural Science; Vol. 5, No. 7; 2013 
 
 
Tumor-promoting and tumor-protective effects of high-fat diets on chemically 
induced mammary cancer in rats. 
Zusman I et al investigated the effects of different dietary fats on experimental rat 
mammary lumorigenesis induced by 9,10-dimethyl-1, 2-benzanthracene (DMBA). 
The olive diet was associated with a significant reduction in the tumorigenic effect of 
 Evaluation Of ASVERADO For Its Anti-Neoplastic Activity Against 7,12- Dimethyl 
benz[a]anthracene (DMBA) Induced Mammary Gland Carcinoma In Female Wistar Rats 
46 
  
 
 
  
DMBA: tumor incidence decreased to 30%, as compared to 44%-55% in the other 
dietary groups studied (p < 0.05). Malignant mammary tissue exhibited higher values 
than benign tissue for all the argyrophilic-nucleolar-organizer region parameters 
measured. The tumor-associated protein p53 was accumulated to high levels in the 
blood of tumor-bearing rats, but not in that of the non tumor-bearing rats. 
Anticancer Res. 1997 Jan-Feb;17(1A):349-56. 
 
Hass Avocado Composition and Potential Health Effects 
Mark L et al investigated that the avocado oil consists of 71% monounsaturated fatty 
acids (MUFA), 13% polyunsaturated fatty acids (PUFA), and 16% saturated fatty 
acids (SFA), which helps to promote healthy blood lipid profiles and enhance the 
bioavailability of fat soluble vitamins and phytochemicals from the avocado or other 
fruits and vegetables, naturally low in fat, which are consumed with avocados. 
 
Crit Rev Food Sci Nutr. 2013 May; 53(7): 738–750. 
 
Activity of Aloe vera: 
 
Clear Evidence of Carcinogenic Activity by a Whole-Leaf Extract of Aloe 
barbadensis Miller (Aloe vera) in F344/N Rats 
Mary D. Boudreau et al investigated on drinking water exposure of F344/N rats and 
B6C3F1 mice to an Aloe vera whole-leaf extract (1, 2, and 3%) for 13 weeks resulted 
in goblet cell hyperplasia of the large intestine in both species. Incidences of 
adenomas and/or carcinomas of the ileo-cecal and cecal-colic junction, cecum, and 
ascending and transverse colon were significantly higher than controls in male and 
female rats in the 1 and 1.5% dose groups. Increased incidences of mucosa 
hyperplasia of the large intestine were observed in F344/N rats, and increased 
incidences of goblet cell hyperplasia of the large intestine occurred in B6C3F1 mice. 
These results indicate that Aloe vera whole-leaf extract is an intestinal irritant in 
F344/N rats and B6C3F1 mice and a carcinogen of the large intestine in F344/N rats. 
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Toxicol Sci. 2013 Jan; 131(1): 26–39 
 
Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in 
F344 rats  
Pandiri AR et al investigated on NTP/NCTR demonstrated a dose-dependent increase 
in large intestinal tumors in F344 rats chronically exposed to Aloe barbadensis Miller 
(Aloe vera) non-decolorized whole leaf extract (AVNWLE) in drinking water. The 
commonly mutated genes (Kras, Ctnnb1, and Tp53) and altered signaling pathways 
(MAPK, WNT, and TGF-β) important in hCRC were evaluated within AVNWLE-
induced large intestinal tumors. In conclusion, the AVNWLE-induced large intestinal 
tumors in F344 rats share several similarities with hCRC at the morphological and 
molecular levels. 
 
Toxicol Pathol. 2011 Dec;39(7):1065-74. doi: 10.1177/0192623311422081. 
 
Safety of purified decolorized (low anthraquinone) whole leaf Aloe vera (L) 
Burm. f. juice in F344 rats 
Shao A, et al investigated on decolorized (purified, low anthraquinone) whole leaf 
Aloe vera (L.) Burm. f. juice was administered at concentrations of 0%, 0.5%, 1% 
and 2% in the drinking water of F344Du rats. Similar concentrations of non-
decolorized (unpurified, high anthraquinone) Aloe vera extracts tested in other studies 
have resulted in an increased incidence and severity of diarrhea and colon adenomas 
and carcinomas. The results of this study supports the assertion that the high levels of 
anthraquinone present in orally administered, non-purified whole leaf Aloe vera 
extract may be responsible for the adverse effects observed on the colon. 
 
Food Chem Toxicol. 2013 Jul;57:21-31. doi: 10.1016/j.fct.2013.03.002 
 
The effects of six weeks endurance training and Aloe Vera on COX-2 and VEGF 
levels in mice with breast cancer 
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Alireza Barari investigated on the effects of the effects of six weeks endurance 
training and Aloe Vera on cyclooxygenase 2 (COX-2) and VEGF levels in mice with 
breast cancer. K-S test to determine the normality of the data and analysis of variance 
for repeated measures and Tukey test was used to analyze the data. A significant 
difference in the p<0.05 accepted. 
 
The Review on Properties of Aloe Vera in Healing of Cutaneous Wounds 
Seyyed Abbas Hashemi et al carried research on natural substance plays crucial role 
as complementary medicine. Various studies reported that aloe vera has useful effects 
on wounds especially cutaneous wounds healing. Therefore in the current review, we 
examined the effect of aloe vera on cutaneous wound healing and concluded that 
although aloe vera improves the wound healing. 
 
Volume 2015 (2015), Article ID 714216, 6 pages 
 
Anti inflammatory activity of extracts from Aloe vera gel 
Beatriz Vázquez, et al investigated the effects of aqueous, chloroform, and ethanol 
extracts of Aloe vera gel on carrageenan-induced edema in the rat paw, and 
neutrophil migration into the peritoneal cavity stimulated by carrageenan. Also 
studied the capacity of the aqueous extract to inhibit  cyclooxygenase activity. The 
aqueous extract inhibited prostaglandin E2 production from arachidonic acid. These 
results demonstrated that the extracts of Aloe vera gel have antiinflammatory activity 
and suggested its inhibitory action on the arachidonic acid pathway via 
cyclooxygenase. 
 
Volume 55, Issue 1, December 1996, Pages 69-75 
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Activity of Ashwagandha: 
 
An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda 
Narendra Singh, et al carried out a research on pretreatment of Withania somnifera 
(WS) showed significance protection against stress induced gastric ulcers. WS have 
anti-tumor effect on Chinese Hamster Ovary (CHO) cell carcinoma. It was also found 
effective against urethane induced lung-adenoma in mice. It was also found useful in 
neurodegenerative diseases such as Parkinson's, Huntington's and Alzeimer's 
diseases. It has GABA mimetic effect and was shown to promote formation of 
dendrites. It has anxiolytic effect and improves energy levels and mitochondrial 
health.  
 
Afr J Tradit Complement Altern Med. 2011; 8(5 Suppl): 208–213 
 
Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative 
diseases 
Kuboyama T, et al investigated on Neurodegenerative diseases commonly induce 
irreversible destruction of central nervous system (CNS) neuronal networks, resulting 
in permanent functional impairments. Ashwagandha (roots of Withania somnifera 
Dunal) is used in traditional Indian medicine (Ayurveda) for general debility, 
consumption, nervous exhaustion, insomnia, and loss of memory. In this review, the 
various effects and mechanisms of Ashwagandha extracts and related compounds on 
in vitro and in vivo models of neurodegenerative diseases such as Alzheimer's disease 
and spinal cord injury. 
 
Biol Pharm Bull. 2014;37(6):892-7 
 
Water Extract of Ashwagandha Leaves Has Anticancer Activity  
 Renu Wadhwa ,et al carried research on anticancer activity in the water extract of 
Ashwagandha leaves (ASH-WEX) was detected by in vitro and in vivo assays. It was reported  
that the ASH-WEX is cytotoxic to cancer cells selectively, and causes tumor suppression in 
vivo. Its active anticancer component was identified as triethylene glycol (TEG). Molecular 
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analysis revealed activation of tumor suppressor proteins p53 and pRB by ASH-WEX and TEG 
in cancer cells. In contrast to the hypophosphorylation of pRB, decrease in cyclin B1 and 
increase in cyclin D1 in ASH-WEX and TEG-treated cancer cells (undergoing growth arrest), 
normal cells showed increase in pRB phosphorylation and cyclin B1, and decrease in cyclin 
D1 (signifying their cell cycle progression).It was found that the MMP-3 and MMP-9 that 
regulate metastasis were down regulated in ASH-WEX and TEG-treated cancer cells; normal 
cells remained unaffected. 
October 10, 2013 https://doi.org/10.1371/journal.pone.0077189 
 
 
Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its 
Component Withanone Involves ROS Signaling 
Nashi Widodo, et al investigated the randomized ribozyme library was introduced 
into cancer cells prior to the treatment with i-Extract. Gene targets of the selected 
ribozymes were analyzed by bioinformatics and pathway analyses. Fifteen gene-
targets were identified and were investigated for their role in specific cancer cell 
killing activity of i-Extract and its two major components (Withaferin A and 
Withanone) by undertaking the shRNA-mediated gene silencing approach. The 
selected gene-targets revealed the involvement of p53, apoptosis and insulin/IGF 
signaling pathways linked to the ROS signaling. It was examined the involvement of 
ROS-signaling components and demonstrate that the selective killing of cancer cells 
is mediated by induction of oxidative stress. 
 
October 21, 2010https://doi.org/10.1371/journal.pone.0013536 
 
Effect of an Extract of Withania somnifera Root on Estrogen Receptor-positive 
Mammary Carcinomas 
KAMEL F. KHAZAL, et al investigated the chemopreventive activity of an extract of 
Withania somnifera (WS) roots was examined in female Sprague-Dawley rats that 
received the mammary carcinogen methylnitrosourea (MNU). Labeling indices for 
Ki67 and proliferating cell nuclear antigen (PCNA) markers in cancers of the treated 
group were 42% and 38% lower, respectively, than those of the corresponding indices 
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for the control group. These results indicate that the root extract significantly reduced 
the rate of cell division in the mammary tumors. 
 
Anticancer Res. 2013 Apr; 33(4): 1519–1523. 
 
Effect of Withania somnifera root extract on spontaneous estrogen receptor-
negative mammary cancer in MMTV/Neu mice. 
Khazal KF, et al carried out a research on the cancer-preventive activity of an extract 
of Withania somnifera (WS) roots was examined in female transgenic (MMTV/Neu) 
mice. The average weights of the carcinomas were 2.36 g for mice in the treated 
group and 2.63 g for the controls, a difference of 10%. Labeling indices for Ki67 and 
proliferating cell nuclear antigen marker in mammary carcinomas of the treated group 
were 35% and 30% lower, respectively, than those of the corresponding control 
group. Expression of the chemokine was reduced by 50%. These results indicate that 
the root extract reduced the number of mammary carcinomas that developed and 
reduced the rate of cell division in the carcinomas. 
 
Anticancer Res. 2014 Nov;34(11):6327-32 
 
In Vitro Anticancer Activity of the Root, Stem and Leaves of Withania 
Somnifera against Various Human Cancer Cell Lines 
B. Yadav, et evaluated in vitro cytotoxicity in 50% ethanol extract of root, stem and 
leaves of Withania Somnifera against five human cancer cell lines of four different 
tissues i.e. PC-3, DU-145 (prostrate), HCT-15 (colon), A-549 (lung) and IMR-32 
(neuroblastoma). Ethanol extract of leaves obtained from treatments T2, T3, T4 and 
T5 showed strong activity against PC-3 and HCT-15 with 80-98% growth inhibition, 
while the 50% ethanol extract of leaves from T1 treatment showed a minimum of 
39% and T3 treatment showed a maximum of 98% growth inhibition against HCT-
15. This investigation is the first report of the anticancer activity in various parts of 
Withania Somnifera. 
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Indian J Pharm Sci. 2010 Sep-Oct; 72(5): 659–663. 
 
Withania somnifera Root Extract Inhibits Mammary Cancer Metastasis and 
Epithelial to Mesenchymal Transition 
Zhen Yang, et al Withania somnifera root extracts (WRE) have anti-proliferative 
activity and the active component, Withaferin A, inhibits the pro-metastatic protein, 
vimentin. Vimentin is an intermediate filament protein and is part of the epithelial to 
mesenchymal transition (EMT) program to promote metastasis. It was determined 
whether WRE standardized to Withaferin A (sWRE) possesses anti-metastatic 
activity and whether it inhibits cancer motility via inhibition of vimentin and the 
EMT program. This sWRE formulation inhibited breast cancer cell motility and 
invasion. These studies were taken into a human xenograft and mouse mammary 
carcinoma model. Taken together, these data support the hypothesis that low 
concentrations of sWRE inhibit cancer metastasis potentially through EMT inhibition. 
 
PLoS One. 2013; 8(9): e75069. Published online 2013 Sep 12. doi:  
10.1371/journal.pone.0075069 
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5.1 Introduction to Herbal Plants 
Persea Americana Mill 
90 
 
Description 
 
A rapidly-growing tree or shrub from Mexico 
and Central America, avocado is well-known for 
its edible, green-fleshed fruits. 
Avocado pear, alligator pear, midshipman‟s 
butter, vegetable marrow, avocatier (French), aguacate (Spanish), avokado (Swedish), 
Butter Fruit 
The avocado belongs to the laurel family (Lauraceae), which includes many aromatic 
trees and shrubs. The common name comes from the Nahuatl (a Mexican language) 
word  ahuácatl, meaning testicle, and refers to the shape of the fruits, an association 
which led to their being considered a fertility food. 
 Avocados have been cultivated for their highly nutritious fruits since about 8,000 
BC, and there is evidence that they were eaten as a wild fruit before then. The oldest 
archaeological record is from Coxcatlan, Mexico, from about 10,000 BC.    
Avocado Leaves
92 
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Avocado Flower
92 
 
 
 
Avocado Fruit
92 
Taxonomy
91 
Kingdom Plantae 
(unranked) Angiosperms 
(unranked) Magnoliids 
Order     Laurales 
Family   Lauraceae 
Genus        Persea 
Species       P. americana 
Binomial name 
Persea americana 
Mill. 
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Active Ingredient and Substances 
90
:  
The leaves contain essential oil (with estragole, caryophyllene and eugenol), 
flavonoids (afzelin, cynaroside, luteolin, quercetin), tannins and procyanidins. 
The avocado fruit is considered one the most nutritious of all fruits and very high in 
calories (220 kcal per 100 g). The fruit contains a fatty oil based on linoleic acid, 
linolenic acid, palmitic acid, stearic acid and other fatty acids, both saturated and 
unsaturated. 
Furthermore, it contains phenols (caffeic acid, chlorogenic acid, p-coumaric acid), 
alpha-carotene, beta-carotene, folic acid, pantothenic acid, fructose, glucose, sucrose, 
fibers, amino acids and small amounts of coenzyme Q10. The avocado pulp contains 
more protein than any other fruit. 
The fruit is loaded with vitamin B1 (thiamine), B2 (riboflavin), B3 (niacin), B6, C, D, 
and E (tocopherols, tocotrienols) and minerals such as calcium, sodium, potassium, 
zinc, iron, phosphorus, copper, manganese and magnesium. 
Avocado oil containing 20-35% saturated fatty acids (palmitic acid, myristic acid, and 
stearic acid), 70 to 85% monounsaturated fatty acids (oleic and palmitoleic acids) and 
10-15% polyunsaturated fatty acids (linoleic and linolenic acids). 
Application of the Leaves, Bark and Seeds of Avocado
 90
: 
1. Remedy for High Cholesterol 
2. Atherosclerosis, Angina Pectoris and Alzheimer‟s Disease 
3. Hypertension and coronary heart disease 
4. Good for the Digestion and Blood Sugar Balance 
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5. Skincare 
6. Avocado Oil Uses in Aromatherapy, Cosmetics and Skincare 
7. Pregnancy, Birth or Puerpuerium Disorders 
8. Aphrodisiac 
9. Diarrhoea, bloating and flatulence,dysentry 
10. Remedy for coughs and gout 
11. Cleanse the liver 
12. Inhibit herpes simplex virus type I and II, which causes cold sores (I) and 
genital herpes (II) 
13. Antibacterial and antifungal properties 
14. Antiviral and anti-inflammatory effects 
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5.2 Aloe vera (L.) Burm.f. 
 
Description
93 
Aloe vera is a stemless or very short-stemmed plant growing to 60–100 cm (24–39 in) 
tall, spreading by offsets. The leaves are thick and fleshy, green to grey-green, with 
some varieties showing white flecks on their 
upper and lower stem surfaces. The margin of 
the leaf is serrated and has small white teeth. 
The flowers are produced in summer on a spike 
up to 90 cm (35 in) tall, each flower being 
pendulous, with a yellow tubular corolla 2–
3 cm (0.8–1.2 in) long. Like 
other Aloe species, Aloe vera forms arbuscular 
mycorrhiza, a symbiosis that allows the plant 
better access to mineral nutrients in soil.  
Aloe vera leaves contain phytochemicals under study for possible bioactivity, such as 
acetylated mannans, polymannans, anthraquinone C-glycosides, anthrones, other 
anthraquinones, such as emodin and various lectins 
Taxonomy
93 
Kingdom Plantae 
Clade Angiosperms 
Clade Monocots 
Order Asparagales 
Family Asphodelaceae 
Subfamily Asphodeloideae 
Genus Aloe 
Species A. vera 
Binomial name Aloe vera ( L.) Burm.f. 
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Active components with its properties
94
:  
 
Aloe vera contains 75 potentially active constituents: vitamins, enzymes, minerals, 
sugars, lignin, saponins, salicylic acids and amino acids. 
 
Vitamins: It contains vitamins A (beta-carotene), C and E, which are antioxidants. It 
also contains vitamin B12, folic acid, and choline. Antioxidant neutralizes free 
radicals. 
Enzymes: It contains 8 enzymes: aliiase, alkaline phosphatase, amylase, bradykinase, 
carboxypeptidase, catalase, cellulase, lipase, and peroxidase. Bradykinase helps to 
reduce excessive inflammation when applied to the skin topically, while others help 
in the breakdown of sugars and fats. 
 
Minerals: It provides calcium, chromium, copper, selenium, magnesium, manganese, 
potassium, sodium and zinc. They are essential for the proper functioning of various 
enzyme systems in different metabolic pathways and few are antioxidants. 
 
Sugars: It provides monosaccharides (glucose and fructose) and polysaccharides: 
(glucomannans/polymannose). These are derived from the mucilage layer of the plant 
and are known as mucopolysaccharides. The most prominent monosaccharide is 
mannose-6-phosphate, and the most common polysaccharides are called 
glucomannans [beta-(1,4)-acetylated mannan]. Acemannan, a prominent 
glucomannan has also been found. Recently, a glycoprotein with antiallergic 
properties, called alprogen and novel anti-inflammatory compound, C-glucosyl 
chromone, has been isolated from Aloe vera gel. 
 
Anthraquinones: It provides 12 anthraquinones, which are phenolic compounds 
traditionally known as laxatives. Aloin and emodin act as analgesics, antibacterials 
and antivirals. 
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Fatty acids: It provides 4 plant steroids; cholesterol, campesterol, β-sisosterol and 
lupeol. All these have anti-inflammatory action and lupeol also possesses antiseptic 
and analgesic properties. 
 
Hormones: Auxins and gibberellins that help in wound healing and have anti-
inflammatory action. 
 
Others: It provides 20 of the 22 human required amino acids and 7 of the 8 essential 
amino acids. It also contains salicylic acid that possesses anti-inflammatory and 
antibacterial properties. Lignin, an inert substance, when included in topical 
preparations, enhances penetrative effect of the other ingredients into the skin. 
Saponins that are the soapy substances form about 3% of the gel and have cleansing 
and antiseptic properties. 
 
 
Application of aloe vera
94
: 
 
1. Antioxidant and antibacterial properties 
 
2. Antitumor activity 
 
3. Accelerates the healing of burns 
 
4. Reduces dental plaque 
  
5. Helps treat mouth ulcers, or canker sores 
 
6. Reduces constipation 
 
7. Effective against other digestive disorders, such as irritable bowel syndrome 
(IBS) and inflammatory bowel disease (IBD) 
 
8. Prevent wrinkles 
 
9. Lowers blood sugar levels in diabetics  
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10. Anti-inflammatory action 
 
11. Effects on the immune system 
 
12. Moisturizing and anti-aging effect 
 
13. Antiseptic effect 
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5.3 Withania somnifera
95
: 
Description: 
Ashwagandha in Sanskrit means "smelling like a horse ", Probably originating from 
the odor of its fresh root which resembles that of a sweaty horse. 
Ashwagandha root is a herb of the ages. It is the 'ginseng' of Ayurvedic medicine. 
Ancient Ayurvedic texts including the Charaka and Sushruta Samhitas praise 
Ashwagandha as a tonic particularly for emaciation in people of all ages of both men 
and women. The species name somnifera means "sleep-inducing" in Latin. 
This species is a short, tender perennial shrub growing 35–75 cm (14–30 in) tall. 
Tomentose branches extend radially from a central stem. Leaves are dull green, 
elliptic, usually up to 10–12 cm (4 to 5 in) long. The flowers are small, green and 
bell-shaped. The ripe fruit is orange-red. 
                        FLOWER        
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LEAVES       FRUIT 
                  
 
       ROOTS 
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Vernacular names
96
   
Ajagandha, Amangura, Amukkirag, Asan, Asana, Asgand, Asgandh, Asgandha, 
Ashagandha, Ashvagandha, Ashwaganda, Ashwanga, Asoda, Asundha, Asvagandha, 
Aswagandha, Avarada, Ayurvedic Ginseng, Cerise d'Hiver, Clustered Wintercherry, 
Ghoda Asoda 
 
 
Taxonomy
97 
 
Kingdom Plantae 
(unranked) Angiosperms 
(unranked) Eudicots 
(unranked) Asterids 
Order Solanales 
Family Solanaceae 
Genus Withania 
Species W. somnifera 
Binomial name Withania somnifera 
 
 
 
Active components with its properties
97
:  
 
Ashwagandha root contains flavonoids and many active ingredients of the 
withanolide class. The distinctive earthy odor and flavor of Ashwagandha is due to 
the presence of certain steroidal lactones or Withanolides. These molecules which are 
steroidal in nature are believed to account for the multiple medicinal applications of 
Ashwagandha.  
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Other major Alkaloids: Somniferine, somnine, somniferinine, withananine, pseudo-
withanine, tropino, pseudotropine, choline, cuscohygrine, isolettetierine, anaferine, 
anahydrine, 3-alpha-gloyloxy tropane, etc. 
 
The ashwagandha consists of alkaloids and steroidal lactones. Withanine is the main 
alkaloid, where as somniferine, somnine, somniferinine, withananine, pseudo-
withanine, tropine, pseudo tropine, choline, cuscohygrine, isopelletierine, anaferine, 
anahydrine. Acyl steryl glucosides namely sitoindoside-v11 and sitoindoside-v111 
have been isolated from the roots. The leaves contain steroidal lactones called as 
withanolides. They have steroidal nucleus, carbon chain and lactone ring. WIthaferin 
and withaferin-A are some of the withanolides. It also contains alcohols like somnitol 
and somnirol, withanic acid, phytosterol, ipuranol and cerotic acid, oleic acid, 
palmitic acid and stearic acid. 
 
 
Uses of Ashwagandha
97
 : 
1. Sedative 
2. Hypnotic 
3. Hypotensive 
4. Respiratory actions 
5. Stimulant 
6. Treatment of bradycardia 
7. Immuno-modulatory agent 
8. Anti-stress agent 
9. Treatment of rheumatism 
10. Treatment of gout 
11. Hypertension 
12. Nerve tonic 
13. Used for skin diseases 
14. Prevents degenerative changes in the bones in arthritic conditions. 
15. Sex stimulant 
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16. Rejuvenator 
17. Strength and vigour promoting drug in geriatrics (old people) 
18. Leaf extract shows activity against Staphylococcus aureus and Ranikhet virus. 
19. It is a natural nutrient for insomnia 
20. It is good hypnotic in Alcoholism. 
21. It stimulates thyroid activity. 
22. Enhances anti-peroxidation of liver. 
23. Decrease high cholesterol levels 
24. It balances the mind (Prana Vata). 
25. Cancer treatment and prevention 
26. It increases the quality and quantity of Ojas, the master coordinator between 
the body and consciousness. 
27. Antioxidant properties 
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 EXPERIMENTAL ANIMAL MODEL FOR CANCER STUDIES 
 
Cancer Model
 98 
 Animals in which cancers occur spontaneously without any alteration of the 
animal's genes or initiation of cancer by chemical treatments. 
 Animals whose genes are altered so that they develop spontaneous tumors of 
the same types and with similar properties as the tumors which those altered 
genes cause in humans. 
 Animals that develop spontaneous tumors if they are exposed to 
environmental factors, such as chemicals or radiation. 
 Animals whose natural, unaltered genetic makeup permits researchers 
to identify the genes that generate susceptibility to cancer development. 
 The utility of the models varies by species, by available research reagents and 
tools to support the studies, and by similarity to the human situation.  The 
most commonly used animal cancer models are rodents - mice and rats.  Other 
cancer models include hamsters, rabbits, dogs, cats, livestock, and fish. 
Rodent cancer models
99 
 Mouse cancer models are well known and are frequently used as models for cancer 
research. Mouse models have revolutionized our ability to study gene and protein 
function in vivo and to better understand their molecular pathways and mechanisms. 
The most common rodent cancer models are xenografts and chemically or genetically 
induced cancers. 
 
Rodent xenograft cancer model
99
: 
In the xenograft cancer model, human or animal cancer cells are transplanted either 
under the skin (ectopic) or into the organ of tumor origin (orthotopic) using 
immunocompromised rodents. Xenograft animal cancer models are a relatively 
inexpensive method for generating in vivo tumors using human and animal cancer 
cell lines. 
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The major disadvantages of the xenograft rodent cancer models that limit the rapid 
translation of research to the human clinic include; effectiveness of specific 
anticancer drugs toward only certain cancer tumors, the superficial vascularization of 
xenograft tumors, and the lack of stroma-tumor interactions. The major limitation of 
xenograft cancer models is that the mice and rats used have compromised immune 
systems, so do not represent the behavior of naturally occurring cancers in humans. 
 
Chemically induced rodent models of cancer
99
: 
Chemically induced rodent models of cancer are developed by exposure to 
carcinogens, eg, DMBA(7,12-Dimethylbenz(a)anthracene), N-Methylnitrosourea 
(MNU), N-butyl-N-(4-hydroxybutyl) nitrosamine, 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone, N-ethyl-N-nitrosourea, azoxymethane(AOM) , benzopyrene, 
urethane, and asbestos fibers. Chemically induced cancer rodenet models help in the 
study of the complex traits of cancer, but require high-throughput sequencing to 
identify the mutations, making the method laborious and time-consuming. 
Genetically engineered mouse models of cancer
99
: 
 Spontaneous Method 
Induction of various oncogenes or suppression of tumor suppressor genes, leading 
to the development of spontaneous cancers. The most commonly used systems are 
Cre-Lox,tetracycline-dependent promoter regulation, and Flp-mediated site-
specific and spontaneous recombination methods. 
 Genetically modified mice are created by microinjection of DNA in the 
pronuclei of fertilized zygotes and the transgene is integrated into the genome. 
 Transgenic mice (SK Gupta) 
Cancer is known to be a disease of genome and a large number of human cancers 
arise from mutation in one or more oncogene or tumor suppressor gene. 
Therefore, inactivation of a particular gene within specific tissues of adult mouse. 
The genetically engineered mouse may serve both as a model of disease as well as 
a model for possible gene therapy. Such mice can be generated either by 
pronuclear injection of DNA or by gene targeting 
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 Nude Mouse Model  
Nude mice have been widely used to test the tumorigenicity of cells or for testing 
of anticancer drugs. These mice are immunologically incompetent because of 
absence of thymus. Neither show mitotic response nor generate cytotoxic effector 
cell. Lack of helper T cells and suppressor T cells. 
 
7,12-Dimethylbenz[a]anthracene (DMBA)  
DMBA is a polycyclic aromatic hydrocarbon that is widely used as a chemical 
carcinogen for induction of mammary tumor model. It is probably the best studied 
polycyclic aromatic hydrocarbon available, besides benzo[a]pyrene
100
. 
 DMBA is an immunosuppressant and a strong mammary tumour specific carcinogen. 
That is why, it is widely used worldwide for studying cancer. The mechanism of 
action of DMBA is basically that of a tumor i`nitiator
101
. 
 
                                                 Structure of 7,12-
Dimethylbenz[a]anthracene 
                                         IUPAC Name: 7,12-Dimethylbenz[a]anthracene  
                                         Synonyms: 9,10-Dimethyl-1,2-benzanthracene  
                                                              1,4-Dimethyl-2,3-
benzophenanthrene 
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Mechanism of Carcinogenesis
102, 103
: 
DMBA is metabolized to 3,4-diol metabolite by cytochrome P450. This metabolite of 
DMBA is considered as the procarcinogen that is finally metabolized by cytochrome 
P450 to 1,2-epoxide-3,4-diol-DMBA which is the ultimate carcinogen and forms 
adducts in DNA. These adducts in the DNA lead to mutations which is a essential 
requirement for the development of tumors. The cytochrome P450 responsible for this 
metabolic activation for decades was assumed to be CYP1A1 Expressed or induced 
CYP1A1 was capable of activating DMBA to the procarcinogen 3,4-diol DMBA. 
That CYP1A1 was crucial in vivo for the development of cancers was then concluded 
from these, often in vitro studies. However, later on it was discovered that the 
regulation of CYP1B1 expression is similar to the that of CYP1A1, and the observed 
in vivo effects could have been equally attributed to CYP1B1. Before 1994, the 
existence of CYP1B1 was not known. A study revealed that in vivo CYP1B1 is the 
predominant enzyme in the metabolic activation of DMBA to carcinogenic 
metabolites and not CYP1A1. CYP1B1 is expressed in human lung, can play an 
important role in the metabolic activation tobacco smoke components like polycyclic 
aromatic hydrocarbons to carcinogenic metabolites.  
 
Metabolic activation of polycyclic aromatic hydrocarbons and the formation of DNA 
adducts are a prerequisite of chemical carcinogenesis, but additional factors are 
required to transform these adducts into mutations and subsequently tumors. 
Metabolic activation mediated by CYP1B1 is the first step in the pathway of chemical 
carcinogenesis leading to tumors. 
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AIM & SCOPE OF WORK 
 
Cancer, being a cause of death for major fraction of population worldwide, is one of 
the most studied diseases and is being investigated for the development of new 
technologies and more accurate therapies. Still the currently available therapies for 
cancer have many lacunae which affect the patient‟s health severely in the form of 
side effects. The natural drugs obtained from the medicinal plants provide a better 
alternative to fight against this devastating disease. 
 
Breast cancer and cancer related diseases have been treated using surgery, 
chemotherapy, and radiation therapy, or a combination of these. Despite these 
therapeutic options, cancer remains associated with high mortality. Traditional 
medicine which involves the use of herbs has been used to treat various types of 
cancer and this has been found to be effective with minimal or no side effects. It was 
also highlighted in introductory part the need of alternative system of herbal medicine 
for treating various ailments. 
 
The review of literature shows many uses and different studies for cancer on 
Avocado, Aloe vera and Ashwagandha. 
 
This research was aimed to evaluate the both in-vitro studies using Breast cancer cell 
line (MCF-7) & in-vivo studies based on the ethanolic extract of ASVERADO for its 
anti-neoplasttic activity against 7,12-dimethylbenzeneanthracene (DMBA) induced 
Mammary gland carcinoma in female Wistar rats. So that it may serve clinically for 
the management of cancer. 
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PLAN OF WORK 
 
PLAN OF WORK: 
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                 Serology 
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10 METHODS AND MATERIALS: 
10.1 Collection and Authentication: 
The fruit of Persea Americana Mill (Lauraceae) were collected from the local source, 
Koyambedu Market, Tamil Nadu, Chennai in the month of March. 
The plant material was identified and authenticated by Prof P.Jayaraman, Ph.D, 
Director: Professor, Presidency College, and Chennai 600005. PLANT ANATOMY 
RESEARCH CENTRE. Tambaram, Tamil Nadu, Chennai-600045. Reg.No 
PARC/2017/3433. A voucher specimen was submitted at C.L. Baid Metha College of 
Pharmacy, Chennai-97. 
 
The leaves of Aloe vera (L.) Burm.f. (Asphodelaceae) were collected from the local 
source, Tamil Nadu, Chennai in the month of March. 
The plant material was identified and authenticated by Prof P.Jayaraman, Ph.D, 
Director: Professor, Presidency College, and Chennai 600005. PLANT ANATOMY 
RESEARCH CENTRE. Tambaram, Tamil Nadu, Chennai-600045. Reg.No 
PARC/2017/3431. A voucher specimen was submitted at C.L. Baid Metha College of 
Pharmacy, Chennai-97. 
 
The dried root powder of Withania somnifera (Solanaceae) was collected from the 
local source, Broadway, Tamil Nadu, Chennai in the month of March. 
The powder material was identified and authenticated by Prof P.Jayaraman, Ph.D, 
Director: Professor, Presidency College, and Chennai 600005. PLANT ANATOMY 
RESEARCH CENTRE. Tambaram, Tamil Nadu, Chennai-600045. Reg.No 
PARC/2017/3432. A voucher specimen was submitted at C.L. Baid Metha College of 
Pharmacy, Chennai-97. 
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10.2 Extraction of ASVERADO: 
1. Preparation of  Ethanolic extract of Avocado: 
The fruit of Persea Americana Mill were collected. The raw material such as fruit 
and seeds were collected separately. Then the fruits were cut into small pieces and it 
was transferred into a white polyethylene cover. And it was kept in a deep freezer at 
2-5ºC for about 5-7 Days. The seeds which were collected separately were shade 
dried for 5 days. 
 
After the 7 days of freezing, the fruits were blended in a mixer and made into fine 
powders which weigh about 400g and dried seeds were also blended and made into 
coarse powder which weighs about 200g. 
 
   
 
                
 
Pieces of Avocado in Deep Freeze 
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 Freezed Avocado                         Fine powder of Avocado 
 
                              
                                                     Avocado Seeds 
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                                     Dried Avocado Seeds 
 
Extraction via Soxhlet Apparatus: 
Dried powders of both seeds were transferred into Soxhlets apparatus. Soxhlet apparatus 
consists of a boiler and reflux which circulates the solvents, a thimble which retains solids to 
be laved. 
The powder to be extracted is introduced into the thimble. The extraction solvent (Ethanol) 
to be placed used is placed in a distillation flask. The distillation flask is placed on heating 
mantle. Heating mantle is maintained at a temperature of 40-50◦C.   
The solvent is heated, and the vapours move towards distillation arms. The flow of water 
should be maintained.  The non-volatile compounds dissolves in the solvent.  At the end of 
this process, the extract remains in the distillation flask.  
After extraction process, if some amount of alcohol remains in the extract it can be 
evaporated by means of distillation process.  In this process, if any traces of alcohol is 
present in the extract it can be evaporated and collected in a separate receiving flask. 
Distillation apparatus consists of round bottom flask, heating mantle, condenser, L-tube, 
receiving flask, water inlet & outlet.  
At the end of this process, the extracted crude compound obtained is a viscous mass.                                                  
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2. Preparation of  Ethanolic extract of Ashwagandha: 
The dried root powder of Withania somnifera was collected and it weighs about 500g. 
The powdered roots were extracted with ethanol in Soxhlet apparatus to obtain the 
viscous mass of crude drug. 
Extraction method is same as mentioned above in Avocado preparation 
  
                                
 Powdered root of Ashwagandha 
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3. Extraction of aloe vera juice: 
The fresh leaves of Aloe vera (L.) Burm.f  were collected. The leaves were peeled off and 
gel was separated. The gel was collected in a vessel. Separated gel was grinded in a 
blender to obtain a white pulpy juice. 
Freshly prepared juice was administered to the experimental animals. 
 
     
         Pieces of Aloe vera gel                                    
 
                               
                  Aloe vera juice 
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10.3 Preparation of ASVERADO: 
Crude product obtained from Avocado, Ashwagandha, Aloe vera after the 
extraction were mixed together in a geometric proportion ratio of 4:4:2 or 2:2:1 
(i.e,) Avocado (4) : Aloe vera (4) : Ashwagandha (2).  
This proportion ratio is used throughout the experiment for studying  Acute 
toxicity, In-vitro studies & In-vivo studies. 
 
10.4 CHEMICALS REQUIREDS: 
All the Chemicals used in the study were of analytical grade. 
The following chemicals were used for the experimental study. 
  
                                    Name of the chemicals and their source 
SL.  
no MATERIALS SOURCE 
1 Chloroform S.d.fine chemicals Ltd, Mumbai 
2 Distilled water Andavar distilled water 
3 DMBA (7,12 Dimethyl benz[a]anthracene) Sigma -Aldrich, Merck 
4 Disodium phosphate S.d.fine chemicals Ltd, Mumbai 
5 Disodium EDTA Chemspure, Chennai 
6 Ether S.d.fine chemicals Ltd, Mumbai 
7 Ethanol S.d.fine chemicals Ltd, Mumbai 
8 Formaline S.d.fine chemicals Ltd, Mumbai 
9 Monosodium phosphate S.d.fine chemicals Ltd, Mumbai 
10 Paclitaxel Sigma -Aldrich, Merck 
11 Sesame oil Sri Sabari Oil Mills  
12 Sodium chloride Paxy specialities Pvt Ltd 
13 Sodium CMC Scope ingredients Pvt Ltd, Chennai 
14 MCF 7 Cell line 
National Centre for Cell Sciences, Pune 
(NCCS) 
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10.5 PRELIMINARY PHYTOCHEMICAL ANALYSIS
105
: 
     The ethanolic extract of ASVERADO was subjected to preliminary 
phytochemical screening for the presence or absence of  phyto-constituents by the 
following methods. 
 
1. Test for alkaloids: 
The extract was treated with dilute hydrochloric acid and filtered. The filtrate is used 
in the following tests. 
a) Mayer‟s reagent (Potassium Mercuric Iodine Solution) 
0.5ml of the extract was treated with Mayer‟s reagent and the appearance of 
cream color indicates the presence of alkaloid. 
 
b) Dragendroff‟s test (Potassium Bismuth Iodide) 
0.5ml of the extract was treated with Dragen droff‟s reagent and the 
appearance of reddish brown color precipitate indicates the presence of alkaloid. 
 
c) Hager‟s test (Saturated solution of Picric acid) 
 
0.5ml of the extract was treated with Hager‟s test and the appearance of 
yellow color precipitate indicates the presence of alkaloid. 
 
d) Wagner‟s test (Iodine-Potassium Iodide Solution) 
 
0.5ml of the extract was treated with Wagner‟s test and the appearance of brown 
color precipitate indicates the presence of alkaloid. 
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2. Test for Carbohydrates: 
a) Molisch‟s test 
The extract was treated with 3ml of alpha-napthol in alcohol and concentrated 
sulphuric acid was added along the sides of the test tube carefully. Formation of 
violet color ring at the junction of two liquids indicates the presence of carbohydrates. 
 
b) Fehling‟s test (CuSO4.7H2O+KOH+Potassium Tartarate) 
The extract was treated with Fehling‟s solution A and B heated in boiling 
water for few minutes. The appearance of reddish brown color precipitate indicates 
the presence of reducing sugars. 
 
c) Benedict‟s test (Sodium citrate + sodium carbonate + CuSO4.7H2O) 
The extract was treated with Benedict‟s test and heated in boiling water for 
few minutes. The appearance of reddish orange color precipitate indicates the 
presence of reducing sugars. 
 
d) Barfoed‟s test (Copper Acetate+ Glacial acetic acid) 
The extract was treated with Barfoed‟s test and heated in boiling water for few 
minutes. The appearance of reddish orange color precipitate indicates the presence of 
non-reducing sugars. 
 
3. Test for steroids 
a) Libermann Burchard test: 
The extract was treated with small quantity of concentrated sulphuric acid, 
glacial acetic acid and acetic anhydride. The appearance of green color indicates the 
presence of steroids. 
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4. Test for proteins: 
 
a) Biuret‟s test: 
 
The extract was treated with copper sulphate and sodium hydroxide solution. 
The appearance of violet color indicates the presence of proteins. 
 
 
b) Millon‟s test: 
The extract was treated with Millon‟s reagent. The appearance of pink color 
indicates the presence of proteins. 
 
5. Test for Tannin‟s 
 
a) The extract was treated with 10% lead acetate solution. The appearance of 
white precipitate indicates the presence of tannins. 
 
b) The extract was treated with aqueous bromine solution. The appearance of 
white precipitate indicates the presence of tannins. 
 
 
6. Test for Phenols 
 
a) The extract was treated with neutral ferric chloride solution. The 
appearance of violet indicates the presence of phenols. 
 
b) The extract was treated with 10% sodium chloride solution. The 
appearance of cream color indicates the presence of phenols. 
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7. Test for Flavonoid‟s 
 
a) 5ml of extract solution was hydrolysed with 10%v/v sulphuric acid 
and cooled. Then, it is extracted with diethyl ether and divided into three 
portions in three separate test tubes. 1ml of diluted sodium carbonate, 1ml of 
0.1N sodium hydroxide, and 1ml of strong ammonia solution were added to 
the first, second and third test tubes respectively. In each test tube, 
development of yellow color demonstrated the presence of flavonoids. 
b) Shinoda‟s test: The extracts were dissolved in alcohol, to that one piece 
of magnesium is added followed by concentrated hydrochloric acid along the 
sides of the test tube drop wise. It is heated in a boiling water bath for few 
minutes. The appearance of magenta colour indicates the presence of 
flavonoids. 
 
 
 
8) Test for Gums and Mucilage 
 
           The extract was treated with 25ml of absolute alcohol and then solution was 
filtered. The filtrate was examined for its swelling properties. 
 
9) Test for Glycosides 
The extract was dissolved in the glacial acetic acid and few drops of ferric 
chloride solution was added, followed by the addition of concentrated sulphuric acid, 
formation of red ring at the junction of two liquids indicates the presence of 
glycosides. 
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10) Test for Saponins 
1ml of the extract was diluted to 20ml with distilled water and shaken well in a 
test tube. The formation of foam in the upper part of the test tube indicates the 
presence of saponins. 
 
11) Test for Terpenes 
The extract was treated with tin and thionyl chloride, appearance of pink color 
indicates the presence of terpenes. 
 
12) Test for sterols 
The extract was treated with 5% potassium hydroxide solution; appearance of 
pink color indicates the presence of sterols. 
11. In vitro screening
99
: 
There are many in vitro methods available for testing anti cancerous activity of a 
compound and the primary evaluation technique is cell culture. In vitro methods are 
less expensive as well as less time-consuming compared to in vivo tumor models, 
thereby allowing evaluation of large quantities of new anticancer agents. 
Sophisticated in vitro experiments provide data on mechanisms of action, by how the 
compounds act on tumour entities when combined with the specific cell lines. Based 
on these data, further selection of promising drugs for in vivo testing can be obtained. 
 
In vitro methods
99
: 
 
There are different types of assays which are used in the in-vitro studies of anti-
cancer. They are 
 
 Tetrazolium salt assay (MTT or Microculture Tetrazolium Test) 
 Sulphorhodamine B assay 
 ³H-Thymidine Uptake assay 
 Dye Exclusion Test 
 Clonogenic assay 
 Cell counting assay 
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Procedure: 
 
 
Cell line and culture
104
: 
 
 MCF 7 cell line was obtained from National Centre for Cell Sciences, Pune (NCCS). 
The cells were maintained in DMEM supplemented with 10% FBS, penicillin (100 
U/ml), and streptomycin (100 μg/ml) in a humidified atmosphere of 50 μg/ml CO2 at 
37 °C.   
 
In Vitro assay for anti cancer activity: (MTT assay)  
 
Cells (1 × 105 /well) were plated in 24-well plates and incubated in 370C with 5% 
CO2 condition. After the cell reaches the confluence, the various concentrations of 
the samples were added and incubated for 24hrs. After incubation, the sample was 
removed from the well and washed with phosphate-buffered saline (pH 7.4) or 
DMEM without serum. 100µl/well (5mg/ml) of 0.5% 3-(4, 5-dimethyl-2-thiazolyl)-
2,5-diphenyl--tetrazolium bromide (MTT) was added and incubated for 4 hours. After 
incubation, 1ml of DMSO was added in all the wells .The absorbance at 570nm was 
measured with UV- Spectrophotometer using DMSO as the blank. Measurements 
were performed and the concentration required for a 50% inhibition (IC50) was 
determined graphically. The % cell viability was calculated using the following 
formula:     
 
% Cell viability = A570 of treated cells / A570 of control cells × 100 
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12.1 ACUTE TOXICITY STUDIES
106
: 
  The procedure was followed by using OECD 423 guidelines 423.The 
acute toxic class method (423) is a step wise procedure with 3 animals of single sex 
per step. Depending on the mortality and/or morbidity status of the animals, on the 
average 2-4 steps may be necessary to allow judgment on the acute toxicity of the 
substances. This procedure results in the use of a specified number of animals while 
allowing for acceptable data- based scientific conclusion. 
The method used defined doses (2000mg/kg body weight) and results allow a 
substance to be ranked and classified according to the Globally Harmonized System 
(GHS) for classification of chemical which cause acute toxicity. 
 
PROCEDURE: 
Adult female Wistar rats, weighs about 180-250kg were used for the study. 
The dose level of Alcoholic extract of ASVERADO was 2000mg/kg body weight p.o. 
as most of the crude extract posses LD50 value more than 2000mg/kg, p.o. so starting 
dose used was 2000mg/g p.o. Dose volume administered was 4ml/100 gm body 
weight to rats which were fasted overnight with water ad libitum. Food was withheld 
for further 3-4hrs after oral administration of drugs. The animals are observed 
individually after dosing at least once during first 30 minutes than periodically during 
the first 24 hours with special attention given during the first 4 hours and thereafter 
for 14 days for any toxic signs and symptoms. 
EVALUATION: 
          Body weight of mice‟s before and after determination were noted and any 
changes in skin and fur, eyes and mucous membrane, respiratory, circulatory, 
autonomic & central nervous system, motor activity and behavior pattern were 
observed and also sign of tremors, convulsion, salivation, diarrhoea, circling, 
 Evaluation Of ASVERADO For Its Anti-Neoplastic Activity Against 7,12- Dimethyl 
benz[a]anthracene (DMBA) Induced Mammary Gland Carcinoma In Female Wistar Rats 
88 
  
 
 
  
depression, excitement, lethargy, sleep and coma were noted. The onset of toxicity 
and signs of toxicity also noted. 
12.2 EXPERIMENTAL DESIGN: 
 
Female Wistar rats at age of 50 days and above were obtained from the animal house of 
C.L.Baid Metha College of Pharmacy ,  Thoraipakkam, Chennai- 97, and housed in 
groups of six at 22±2◦C in acrylic cages (26cm×48cm×21 cm) for 7 days for 
acclimation to the animal colony, with 12hrs light/dark cycle and access to protein 
diet which consists of  various ingredients such as 47% Chick pea, 13% Wheat flour, 
10% Red kidney bean, 7% Soy beans, 5% Ground nut, 3% Milk powder, 10% Split 
Red Lentil,5% Melon seeds and glucose water ad libitum. Post-surgical housing was 
individual for 7 days to allow recovery. Ethical committee clearance was obtained 
from IAEC (Institutional Animal Ethics Committee) of  
CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on 
Animals). 
                                                  IAEC NO: IAEC/L/05/CLBMCP/2017 
                After recovery of rats, the animals were assigned as follows: 
SL.no GROUPING TREATMENT DURATION 
1 Group-I  Control Saline water, p.o 13 Weeks 
2 
Group-II  Negative 
control DMBA in sesame oil, p.o / i.p 
13 Weeks 
(Two doses) 
1st week & 5th 
week 
3 Group-III Standard Paclitaxel in saline, i.p 
From 9th 
week- 13th  
Week(Weekly 
dosing) 
4 Group-IV Low Dose (mg) ASVERADO in sodium CMC, p.o 
From 9th 
week- 13th 
week(Regular 
dosing) 
5 Group-V High Dose (mg) ASVERADO in sodium CMC, p.o 
From 9th 
week- 13th 
week(Regular 
dosing) 
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12.3 INDUCTION OF DMBA, ASVERADO & PACLITAXEL: 
DMBA 
 By Intragastrically (1st week) 
DMBA was given intragastrically by gavage using cannula fitted to a feeding needle. 
 In flank region (5th week) 
DMBA was given intraperitoneally in the flank region.  
To prepare a dose of 20mg/ml of DMBA, 20mg of DMBA powder was dissolved in 
the 1ml of sesame oil. Standard dose of DMBA is 20mg/ml 
 
ASVERADO 
The extract was given intragastrically by gavage using cannula fitted to a feeding 
needle. 
To prepare an ASVERADO extract solution, the dose is calculated based on the 
animal weight and dissolved in the 0.5% Sodium CMC. Dose is calculated using 
below mentioned formula: 
                        Dose administered= Body weight x Standard dose 
 1000 
Extract high dose is 400mg/kg* 
Extract low dose is 200mg/kg* 
NOTE*: The high dose and low dose value are selected based on the acute toxicity 
studies. 
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PACLITAXEL 
The standard drug Paclitaxel was given intra peritoneally in normal saline. Standard 
dose of paclitaxel is 1mg/kg. 
To prepare a Paclitaxel solution, the dose is calculated based on animal weight and 
dissolved in 0.9% saline. 
 
METHODOLOGY: 
GROUP I (Normal control group): Animals were treated with only saline water for 13 
weeks. 
GROUP II (DMBA administered control group): Animals were subjected to a two 
doses of 20mg of DMBA in sesame oil. 
GROUP III (Standard group): Animals were treated with 20mg/ml of two doses of 
DMBA + 1mg/ml/week of Paclitaxel in Saline solution. 
GROUP IV (Extract Low dose): Animals were treated with 20mg/ml of two doses of 
DMBA + 200mg/ml/day of extract. 
GROUP V: (Extract High dose): Animals were treated with 20mg/ml of two doses of 
DMBA + 400mg/ml/day of extract. 
12.4 TERMINATION OF EXPERIMENTAL ANIMALS:  
After the 13
 
weeks of experimental duration, the blood was collected from the 
animals by retro-orbital puncture & by cervical dislocation for evaluation of Blood 
parameters and Anti-oxidant assay. 
Immediately after the collection, the blood was centrifuged for 10 min at 3000rpm. 
After the centrifugation, the serum and plasma gets separated. The plasma is 
discarded and serum is evaluated for the Serology study such as RBC, WBC, Blood 
sugar level, Hb, Ht, total protein binding,SOD, ESR,Eisnophils. 
Breast,Liver and Kidney were dissected from the body and transferred to a container 
containing 10% Buffered Formalin Solution for the evaluation of histopathological 
studies. 
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PARAMETERES: 
Effect of haematological parameters: 
The effect on haematological parameters in rats following 13 weeks oral administration 
of ethanolic extracts of ASVERADO for toxicity study are presented. Percent 
haemoglobin (% Hb) and total erythrocyte count (TEC) were found to decretase 
significantly (p<0.05) in ASVERADO treated animals compared to control group animals. 
Packed cell volume (PCV) also decreased in the ASVERADO group but the decrease was 
non-significant. 
There was no change in total leucocyte count (TLC) in TPHE treated animals although 
differential leucocyte count chamged significantly (p<0.05) in case of lymphocytes, 
monocytes, neutrophils and eosinophils. Neutrophils and eosinophils were found to 
increase in ASVERADO treated animals while lymphocytes and monocytes were 
decreased compared to control. 
 
Serum biochemical profile  
 
The effect of ASVERADO on serum biochemical parameters in mammary tumour 
bearing rats following 13 weeks oral administration The levels of total protein, albumin 
and globulin were found to decrease significantly (p<0.05) in animals of cancer control 
group compared to normal animals while these values increased significantly in all the 
treatment groups compared to cancer control group.  
 
Oxidative stress related parameters: 
Estimation Of Antioxidant Enzymes: 
Reagents 
1. Carbonate buffer (100mM, pH 10.2) 
2. Epinephrine (3mM) 
Procedure 
The SOD activity in supernatant was measured by the method of Misra and 
Fridovich. The supernatant (500μl) was added to 0.800ml of carbonate buffer 
(100mM, pH 10.2) and 100μl of epinephrine (3mM). The change in 
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absorbance of each sample was then recorded at 480nm in 
spectrophotometer for 2min at an interval of 15sec. Parallel blank and 
standard were run for determination of SOD activity. 
One unit of SOD is defined as the amount of enzyme required to produce 50% 
inhibition of epinephrine auto oxidation.  
Reagents 
Uninhibited 
(Standard) 
Inhibited 
(Sample) Blank 
Carbonate 
buffer 0.900ml 0.800ml 1.0ml 
Supernatant - 0.1ml  - 
Epinephrine 0.1ml 0.1ml  - 
 
The reaction mixtures are diluted 1/10 just before taking the readings in 
spectrophotometer 
Calculation 
%            = 
∆A
480nm ⁄min Uninhibited − ∆A480nm⁄min inhibited 
 
× 100 ∆A480nm ⁄min Uninhibited − ∆A480nm⁄min Blank 
⁄  = 
%Inhibition × Vt 
 
(50%) × Vs  
⁄ = 
Units ⁄ ml enzyme 
  
mg protein ⁄  ml enzyme 
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Where, 
 
Vt = Total volume (1.0ml) 
 
Estimation of Catalase (CAT) 
 
 
Reagents 
 
1.Phosphate buffer solution (50mM) 
 
 
i. Dissolve 6.81g of KH2PO4 in 1000ml distilled water 
 
ii. Dissolve 6.9g of Na2HPO4 in 1000ml distilled water 
 
 
390ml from solution (A) are mixed with 610ml from solution (B), the pH is 
adjusted to 7 
 
2.Hydrogen peroxide (H2O2) 30mM 
 
 
0.34ml of 30% H2O2 is diluted with phosphate buffer to 100ml 
 
 
Procedure 
Catalase activity was measured by the method of Aebi. 0.1ml of 
supernatant was added to cuvette containing 1.9ml of 50mM phosphate buffer (pH  
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7.0). Reaction was started by the addition of 1.0ml of freshly prepared 30mM H2O2. 
The rate of decomposition of H2O2 was measured spectrophotometrically from 
changes in absorbance at 240nm. Activity of catalase was expressed as units/mg 
protein. A unit is defined as the velocity constant per second. 
 
 
 
 
 
 
The reaction occurs immediately after the addition of H2O2. 
 
 
Solutions are mixed well and the first absorbance (A1) is read after 15sec (t1) 
and the second absorbance (A1) after 30sec (t1). The absorbance is read at wavelength 
240nm. 
Calculation 
 
= Vt/Vs×2.3/Δt×logA1/A2× 60 
 
Where, 
K =Rate constant of the reaction 
Δt = (t2-t1) = 15sec 
A1 = Absorbance after 15sec 
A2 = Absorbance after 30sec 
Vt = Total volume (3ml) 
Vs = Volume of the sample (0.1ml) 
 
 
 
Reagents Sample Blank 
Phosphate 
buffer 1.9ml 2.9ml 
Supernatant 0.1ml 0.1ml 
H2O2 1 ml  - 
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Estimation of Lipid peroxidase (LPO) 
 
The level of Lipid peroxidase was estimated by Thiobarbituric acid reaction method 
described by Ohkawa et al 
Reagents  
1. Sodium dodecyl sulphate (SDS) (8.1% w/v)  
2. Acetic acid (20%; pH 3.5)  
3. Thiobarbituric acid (TBA) (0.8%)  
4. n-butanol/pyridine mixture (15:1)  
 
 
Procedure 
To 0.2ml of test sample, 0.2ml of SDS, 1.5ml of acetic acid and 1.5ml of TBA were 
added. The mixture was made up to 4ml with water and then heated in a water bath at 
95°C for 60min. After cooling, 1ml of water and 5ml of n-butanol/pyridine mixture were 
added and shaken vigorously. After centrifugation at 4000rpm for 10min, the organic 
layer was taken and its absorbance was read at 532nm. The level of lipid peroxides was 
expressed as nmoles of MDA released/g wet tissue. 
 
 
Reagents Sample Blank 
SDS 0.2ml 0.2ml 
Supernatant 0.2ml  - 
DDW 1.6ml 108ml 
Acetic acid 1.5ml 1.5ml 
TBA 1.5ml 1.5ml 
n-butanol/pyridine 5ml 5ml 
 
Calculation:  
  = Absorbance at 532nmL ×Є×D 
Where, 
L = Light path (1cm) 
Є = Extinction co-efficient 1.56x105 M-1cm-1  
 
       D =       Total volume (10ml) 
           Volume of the sample (0.2ml) 
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Methods for Histopathological study: 
 
The rats from each group were anaesthetized using intraperitoneal injection of sodium 
pentobarbital (50mg/kg). The organs such as Breast, Kidney, Liver, Spleen was carefully 
removed without injury. The collected organs were washed with ice cold normal saline 
and fixed in 10% formal saline (10ml of formaldehyde in 90ml of physiological saline 
dye. The sections were examined microscopically for histopathological changes. 
  
Statistical Analysis: 
The statistical analysis was carried by one way ANOVA followed by Dunnet’s “t” test. P value 
<0.05 (95% confidence limit) was considered statistically significant, using software Graph 
Pad Prism version6 
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RESULTS: 
 Extraction yield: 
  
The alcoholic of extract of Ashwagandha was dark chocolate brown in colour and was 
stored in refrigerator until use. The percentage yield of the extract was 13.02% w/w. 
The alcoholic extract of Avocado was dark chocolate brown in colour and was stored in 
refrigerator untilcent use. The percentage yield of the extract was 16.22%w/w 
The fresh juice of aloe vera was white pulpy in colour. The percentage yield was 5%w/v 
 
Preliminary Phytochemical study:  
The ethanolic extract of ASVERADO showed presence of various Phyto-chemical 
constituents such as alkaloids, carbohydrate, proteins, tannins, steroids, glycosides, 
flavonoids, and saponins. Results are shown in Table 1 
 
In-vitro assay for Anti-cancer activity (Cell line): 
The ethanolic extract of ASVERADO showed effect on MCF 7 cell line with the 49.43% 
of inhibition of cell viability at 125µg/ml of concentration. Results are shown in Table 2, 
Graph 1 
Acute Toxicity study:  
 
According to the OECD guideline 423 (Acute toxic class method) acute oral toxicity 
studies were performed. A single starting dose of 2000mg/kg p.o was administered to the 
animal and observed for three days. There was no significant change in body weight of 
the animals before and after treatment of drug and no signs of toxicity was found and the 
animals were observed for 14 days. No signs of toxicity were found. Results are shown in 
Table 3. 
EFFECT OF HAEMOTOLOGICAL PARAMETER: 
The Group II animals showed a significant decrease in Haematological parameter when 
compared to the Group I animals. Treatment with AVERADO (200&400 mg/kg) 
significantly increased the Haematological blood parameter (Group III & Group IV) on 
comparison with Group II. There was significant difference in the repetitive / stereotypic 
behavior of both Group I and Group II animals. Treatment with ASVERADO (200& 
400mg/kg) significantly decreased the number and duration of repetitive / stereotypic 
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activity. Results are given in Table4 & Table 5 and represent, Graph 2, Graph 3, Graph 4, 
Graph 5, Graph 6  
Serum biochemical profile: 
 
The effect of ASVERADO on serum biochemical parameters in mammary tumour 
bearing rats following 13 weeks oral administration The levels of total protein, albumin 
and globulin were found to decrease significantly (p<0.05) in animals of cancer control 
group compared to normal animals while these values increased significantly in all the 
treatment groups compared to cancer control group. This recovery was maximum in 
ASVERADO 400 when compared with ASVERADO 200. Results are given in Table 6 
and represents, Graph 7, Graph 8 
Estimation of Antioxidant Enzymes: 
Effect of ASVERADO on Superoxide dismutase: 
SOD level in the Breast of Group II animals was decreased significantly on comparison 
with Group I animals. Treatment with AVERADO 200mg/kg and 400mg/kg (group III & 
Group IV) showed significant increase in SOD level on comparison with Group II animals. 
Results are given in Table 7 and represents, Graph 9 
SOD level in the Kidney of Group II animals was decreased significantly on comparison 
with Group I animals. Treatment with AVERADO 200mg/kg and 400mg/kg (group III & 
Group IV) showed significant increase in SOD level on comparison with Group II animals. 
Results are given in Table 7 and represents, Graph 9 
SOD level in the Liver of Group II animals was decreased significantly on comparison 
with Group I animals. Treatment with AVERADO 200mg/kg and 400mg/kg (group III & 
Group IV) showed significant increase in SOD level on comparison with Group II animals. 
Results are given in Table 7 and represents, Graph 9 
SOD level in the Spleen of Group II animals was decreased significantly on comparison 
with Group I animals. Treatment with AVERADO 200mg/kg and 400mg/kg (group III & 
Group IV) showed significant increase in SOD level on comparison with Group II animals. 
Results are given in Table 7 and represents, Graph 9 
 
Effect of ASVERADO on Catalase: 
Catalase level in the Breast of Group II animals were found decreased 
significantly on comparison with Group I animals. Treatment with ASVERADO 200 
 Evaluation Of ASVERADO For Its Anti-Neoplastic Activity Against 7,12- Dimethyl 
benz[a]anthracene (DMBA) Induced Mammary Gland Carcinoma In Female Wistar Rats 
99 
  
 
 
  
and 400mg/kg (Group III& Group IV) showed significant increase in catalase level 
on comparison with Group II animals. Table 8 and represents, Graph 10 
Catalase level in the Kidney of Group II animals were found decreased 
significantly on comparison with Group I animals. Treatment with ASVERADO 200 
and 400mg/kg (Group III& Group IV) showed significant increase in catalase level 
on comparison with Group II animals. Table 8 and represents, Graph 10 
Catalase level in the Liver of Group II animals were found decreased 
significantly on comparison with Group I animals. Treatment with ASVERADO 200 
and 400mg/kg (Group III& Group IV) showed significant increase in catalase level 
on comparison with Group II animals. Table 8 and represents, Graph 10 
Catalase level in the Spleen of Group II animals were found decreased 
significantly on comparison with Group I animals. Treatment with ASVERADO 200 
and 400mg/kg (Group III& Group IV) showed significant increase in catalase level 
on comparison with Group II animals. Table 8 and represents, Graph 10 
Effect of ASVERADO on Lipid peroxidation 
Lipid peroxidation in the Breast of Group II animal were found increased 
significantly on comparison with ASVERADO 200& 400mg/kg (Group III & Group 
IV) showed significant decrease in lipid peroxidation on comparison with Group II 
animals. Table 9 and represents, Graph 11 
Lipid peroxidation in the Kidney of Group II animal were found increased 
significantly on comparison with ASVERADO 200& 400mg/kg (Group III & Group 
IV) showed significant decrease in lipid peroxidation on comparison with Group II 
animals. Table 9 and represents, Graph 11 
Lipid peroxidation in the Liver of Group II animal were found increased 
significantly on comparison with ASVERADO 200& 400mg/kg (Group III & Group 
IV) showed significant decrease in lipid peroxidation on comparison with Group II 
animals. Table 9 and represents, Graph 11 
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Lipid peroxidation in the Spleen of Group II animal were found increased 
significantly on comparison with ASVERADO 200& 400mg/kg (Group III & Group 
IV) showed significant decrease in lipid peroxidation on comparison with Group II 
animal. Table 9 and represents, Graph 11 
 
 
Tables & Graphs 
 
Table 1: Preliminary Phytochemical study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SL.no Constituents Remarks 
1 Alkaloids Present 
2 Carbohydrates Present 
3 Proteins Present 
4 Steroids Present 
5 Phenols Absent 
6 Tannins Present 
7 Glycosides Present 
8 Flavonoids Present 
9 Saponins Present 
10 Terpens Absent 
11 Gum & Mucilage Absent 
12 Sterols Absent 
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In-vitro assay for Anti-cancer activity (Cell line): 
 
 Table 2: Anticancer effect of Sample on MCF 7 cell line 
 
S.No 
Concentration 
Dilutions 
Absorbance Cell viability 
(µg/ml) (O.D) (%)   
1 1000 Neat 0.204 28.57 
     
2 500 1:1 0.255 35.71 
     
3 250 1:2 0.301 42.15 
     
4 125 1:4 0.353 49.43 
     
5 62.5 1:8 0.405 56.72 
     
6 31.2 1:16 0.458 64.14 
     
7 15.6 1:32 0.512 71.70 
     
8 7.8 1:64 0.559 78.29 
     
9 Cell control - 0.714 
100 
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Calculation: 
 
% Cell viability = A570 of treated cells / A570 of control cells × 
100 
 =0.559/0.714 X 100 
 =0.7829 X 100 
 =78.29% 
Therefore,    
          % Cell viability = A570 of treated cells / A570 of control cells × 100 
 =0.353/0.714X100 
 =0.4943 
 % Cell viability =49.43% in 125µg/ml 
 
Graph 1:  Anticancer effect of Sample on MCF 7 cell line 
  Cell Viability (%)  
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Graphs are plotted using the % of Cell Viability at Y-axis and concentration of the 
sample in X-axis. Cell control and sample control is included in each assay to 
compare the full cell viability assessments. 
Anticancer effect of Sample on MCF 7 cell line 
Normal MCF 7 cell line 
 
 
 
 
 
 
 
Toxicity-1000 µg/ml                                    Toxicity-125 µg/ml 
 
 
 
 
 
 
 
Toxicity- 7.8 µg/ml 
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Table 3: Acute oral toxicity results of ASVERADO 
 
 
 
Evaluation of Blood parameters: 
Table 4 & 5: Heamatological Profile of DMBA Induced Mammary gland Cancer: 
Table 4  
SL.NO Treatment Hb (g/dl) PCV TEC TLC 
1 Control 
12.00 ± 
0.43 
38.33 ± 
1.58 6.38 ± 0.21 9.10 ± 0.37 
2 
Negative 
Control 6.78 ± 0.23* 
25.60 ± 
1.10** 
3.47 ± 
0.23** 5.34 ± 0.24** 
3 Standard 
11.95 ± 
0.44 
35.40 ± 
1.20 6.50 ± 0.43 8.16 ± 0.67 
4 ASVERADO 200 8.66 ± 0.32 
30.78 ± 
1.25** 5.53 ± 0.24 7.10 ± 0.46* 
5 ASVERADO 400 
11.56 ± 
0.41* 
35.03 ± 
1.50 
6.28 ± 
0.49** 8.88 ± 0.76 
 
SL.no Treatment Dose 
Weight of animals 
Sign of 
toxicity 
Onset 
of 
toxicity 
Reversible 
or 
Irreversible Duration 
Before
(kg) After(kg) 
1 ASVERADO 
2000mg
/kg 160 161 
No sign of 
toxicity Nil Nil 
14 Days 
2 ASVERADO 
2000mg
/kg 150 150 14 Days 
3 ASVERADO 
2000mg
/kg 160 162 14 Days 
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Table 5 
 
SL.NO Treatment Lymphocyte Monocyte Eosinophil Basophil 
1 Control 
72.24 ± 
1.67  3.06 ± 0.12 
2.12± 
0.06** 0.15 ± 0.02 
2 
Negative 
Control 
35.27± 
1.50** 
2.54 ± 
0.13** 3.17 ± 0.16 0.11 ± 0.11 
3 Standard 
70.72 ± 
2.22 3.01 ± 0.10* 2.57 ± 0.08 0.13 ± 0.01* 
4 ASVERADO 200 
63.95 ± 
1.83* 2.68± 0.10 2.25 ± 0.08* 0.13 ± 0.10 
5 ASVERADO 400 
68.27 ± 
2.10 2.77 ± 0.07 2.47 ± 0.05 0.15 ± 0.01** 
 
* Denotes significant difference at p<0.05 compared to normal control; *Denotes 
significant difference at p<0.05 compared to cancer control within column (Mean ± SEM, 
n=6) 
                     Values are represented in Mean ± SEM, n=6  
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV  
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet‟s„t‟ test  
                        ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
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Graph 2 (Haemoglobin count) 
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Graph 3 (PCV count) 
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Graph 4 (TEC count) 
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 Graph 5 (TLC count) 
 
 
T L C
G ro u p s
1
0
3
/µ
l
C
o
n
tr
o
l
N
e
g
a
ti
v
e
 C
o
n
tr
o
l
S
ta
n
d
a
rd
A
S
V
E
R
A
D
O
 2
0
0
A
S
V
E
R
A
D
O
 4
0
0
0
5
1 0
1 5
2 0
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluation Of ASVERADO For Its Anti-Neoplastic Activity Against 7,12- Dimethyl 
benz[a]anthracene (DMBA) Induced Mammary Gland Carcinoma In Female Wistar Rats 
 
110 
  
 
 
  
 Graph 6 (Differential leukocyte count) 
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EFEECT OF ASVERADO ON SERUM BIOCHEMICAL PROFILE: 
 TABLE 6:  EFEECT OF ASVERADO ON SERUM BIOCHEMICAL PROFILE: 
 
SL.NO Treatment 
Total 
protein 
(g/dl) 
Albumin 
(g/dl) 
Globulin 
(g/dl) A:G 
1 Control 7.13 ±0.19 
4.28 
±0.14 
2.86 
±0.09 
1.49 
±0.08 
2 
Negative 
Control 
4.63 
±0.25 
2.52 
±0.11* 
2.10 
±0.08** 
1.21 
±0.07 
3 Standard 
6.38 
±0.29 
3.88 
±0.12* 2.49±0.19** 
1.55 
±0.14 
4 ASVERADO 200 
5.90 
±0.42* 
3.49 
±0.32* 2.21 ± 0.13 1.45±0.02 
5 ASVERADO 400 
6.15 
±0.31* 3.66 ± 0.17 2.32±0.18 1.52±0.10 
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* Denotes significant difference at p<0.05 compared to normal control; *Denotes 
significant difference at p<0.05 compared to cancer control within column (Mean ± SEM, 
n=6) 
                     Values are represented in Mean ± SEM, n=6  
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV  
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test  
                        ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
Graph: 7 EFEECT OF ASVERADO ON SERUM BIOCHEMICAL PROFILE: 
 
g
/d
l
C
o
n
tr
o
l
N
e
g
a
ti
v
e
 C
o
n
tr
o
l
S
ta
n
d
a
rd
A
S
V
E
R
A
D
O
 2
0
0
A
S
V
E
R
A
D
O
 4
0
0
0
1
2
3
4
5
A lb u m in
G lobu lin
 
Graph: 8 EFEECT OF ASVERADO ON SERUM BIOCHEMICAL PROFILE 
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Evaluation of Anti-oxidant property: 
Effect of ASVERADO on Superoxide dismutase 
Table 7: Effect of ASVERADO on Superoxide dismutase 
SL.NO Treatment SOD (mg/wet tissue) 
1 Control 5.56±0.30 
2 Negative Control 3.30±0.15*** 
3 Standard 5.32±0.10 
4 ASVERADO 200 4.40±0.18 
5 ASVERADO 400 5.15±0.08 
 
 
                 Values are represented in Mean ± SEM, n=6  
 
Comparison: a- Group I vs Group II, b- Group II vs Group III and Group IV  
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test  
               ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
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Graph 9: EFEECT OF ASVERADO ON SERUM BIOCHEMICAL PROFILE 
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Effect of ASVERADO on Catalase 
Table 8: Effect of ASVERADO on Catalase 
 
SL.NO Treatment  Catalase (mg/wet tissue)  
1 Control 6.25±0.17 
2 Negative Control 3.47±0.15*** 
3 Standard 5.32±0.22 
4 ASVERADO 200 4.79±0.27*** 
5 ASVERADO 400 5.10±0.22*** 
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                                Values are represented in Mean ± SEM, n=6  
 
Comparison:    a- Group I vs Group II, b- Group II vs Group III and Group IV  
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test  
          
                             ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
 
 
  
Graph 10: Effect of ASVERADO on Catalase 
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Effect of ASVERADO on LIPID PEROXIDASE: 
 
Table 9: Effect of ASVERADO on Catalase: 
 
SL.NO Treatment  Lipid peroxide (mg/wet tissue)  
1 Control 6.8±0.38 
2 Negative Control 3.88±0.19 
3 Standard 6.16±0.18 
4 ASVERADO 200 4.52±0.17 
5 ASVERADO 400 5.96±0.37 
 
Values are represented in Mean ± SEM, n=6  
 
Comparison:    a- Group I vs Group II, b- Group II vs Group III and Group IV  
Statistical significance test for comparison was done by one way ANOVA followed by 
Dunnet’s‘t’ test  
          
                             ns- Non significant, *p<0.05, **p<0.01, *p<0.001 
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Graph 11: Effect of ASVERADO  on  LIPID PEROXIDASE 
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HISTOPHATHOLOGY OF BREAST 
Control Group 
 
  
 
Negative Group 
 
Standard 
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Low Dose 
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High dose 
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HISTOPATHOLOGY OF SPLEEN: 
 
Control Group 
 
 
 
                                                                         Negative control 
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            NO TUMOR DEVELOPMENT 
 
Standard  
 
 
            NO TUMOR DEVELOPMENT 
Low Dose 
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          NO TUMOR DEVELOPMENT 
High Dose 
 
 
         NO TUMOR DEVELOPMENT 
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        HISTOPATHOLOGY OF KIDNEY 
Control Group 
 
 
 
 
        NO TUMOR DEVELOPMENT 
 
Negative Group 
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           NO TUMOR DEVELOPMENT 
 
Standard Group 
 
 
            
               NO TUMOR DEVELOPMENT 
 
Low dose 
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             NO TUMOR DEVELOPMENT 
High Dose 
 
 
                
           NO TUMOR DEVELOPMENT 
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 HISTOPATHOLOGY OF LIVER 
 
Control Group 
 
 
 
Negative Control 
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                    NO TUMOR DEVELOPMENT 
 
Standard 
 
 
 
                 NO TUMOR DEVELOPMENT 
Low Dose 
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                        NO TUMOR DEVELOPMENT 
 
High Dose 
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DISCUSSION: 
Cancer, also called malignancy, is an abnormal growth of cells². It is one of the most 
worldwide spread diseases³. Cancer appears as a mass or ulcerates. Cancer is a “great 
imitator”4. It represents a group of several diseases characterized by uncontrolled cell 
division and growth resulting in tumours, if malignant, may spread to other parts of the body. 
Neoplastic cells originate from differentiated and specialized cells through a process of 
regression and de differentiation to a simpler; more primitive stage which divides 
continuously unlike the normal parent cells. The characteristic properties of neoplasia 
include; sustained proliferation, evasion of growth suppressors, immortality, anaplasia , 
continued replication, angiogenesis, reprogramming energy metabolism, invasion, metastasis, 
and escaping immune destruction
5. 
The multistep process including initiation, promotion, and progression of carcinogenesis is a 
complicated process that results from excessive production of oxidative radicals, DNA 
alterations, and lastly the loss of the normal regulatory pathways between cell proliferation, 
differentiation, and apoptosis
6,7
. Progress made in cancer therapy has not been sufficient to 
minimize the annual death rates. The currently used conventional anticancer drugs are also 
toxic to normal cells in addition to being toxic to cancer cells
8
. Hence, there is a greater need 
for new effective and safe strategies in cancer control and therapy. Prevention is the most 
practical strategy to control occurrence and spread of cancer. Cancer chemoprevention aims 
to stop or reverse the development and progression of precancerous cells through the use of 
non-cytotoxic nutrients and/or pharmacologically active agents. It is also important to provide 
various cancer chemopreventive natural agents with different specific molecular and cellular 
targets, which act through multiple mechanisms
9 
Breast cancer is a malignant tumor that starts in the cells of the breast. A malignant 
tumor is capable of invading surrounding tissues or spreading or metastasizing to 
distant areas of the body. The disease occurs almost entirely in women, but men can get 
it, too
23, 24
.  
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Endocrine therapy targets estrogen receptor-positive breast cancers and represents the 
most effective treatment for them. In the last four decades, several hormonal agents 
have been used in palliative settings for advanced cancer and as adjuvant therapy to 
prevent the recurrence. However, there are several proposed molecular mechanisms 
that explain endocrine resistance in a large proportion of patients, which limit the 
effectiveness of endocrine treatments
28, 29,30 
. 
7,12-Dimethylbenz[a]anthracene (DMBA) is an immunosuppressor and a powerful organ-
specific laboratory carcinogen. DMBA serves as a tumor initiator
107
. Tumor promotion can 
be induced with treatments of 12-O-tetradecanoylphorbol-13-acetate (TPA) in some models 
of two-stage carcinogenesis
108
. 
ASVERADO is the herbal product with the combination of Ashwagandha, Aloe vera, 
Avocado. It consists of tumour suppressing constituent ß-carotene .  This constituent act on 
BRAC 1, BRAC 2 and p53 receptor which play major role in suppressing mammary gland 
carcinogenesis. 
BRCA1 and BRCA2 are normally expressed in the cells of breast and other tissue, where 
they help repair damaged DNA, or destroy cells if DNA cannot be repaired. They are 
involved in the repair of chromosomal damage with an important role in the error-free repair 
of DNA double-strand breaks.
109,110
 If BRCA1 or BRCA2 itself is damaged by a BRCA 
mutation, damaged DNA is not repaired properly, and this increases the risk for breast 
cancer
111,112
. BRCA1 and BRCA2 have been described as "breast cancer susceptibility genes" 
and "breast cancer susceptibility proteins". The predominate allele has a normal, tumor 
suppressive function whereas high penetrance mutations in these genes cause a loss of tumor 
suppressive function which correlates with an increased risk of breast cancer
113
. 
This research was aimed to evaluate the both in-vitro studies using Breast cancer cell line 
(MCF-7) & in-vivo studies based on the ethanolic extract of ASVERADO for its anti-
neoplasttic activity against 7,12-dimethylbenzeneanthracene (DMBA) induced Mammary 
gland carcinoma in female Wistar rats. 
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The mammary gland is highly sensitive to oxidative damage because of its high oxygen 
consumption. Thus, oxidative biomarkers such as superoxide dismutase (SOD), catalase 
(CAT), gl), lipid peroxidase (LPO) are analysed to study the severity of the disease and effect 
of the drug on it. Level of SOD, CAT, were found to be decreased in affected rats and LPO 
was observed to be high in its concentration when compared to normal rats. The rats those 
were treated with ASVERADO were observed to possess antioxidant activity showing the 
level of above mentioned oxidative biomarkers similar to normal rats. 
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SUMMARY: 
The present study was conducted for evaluation of ameliorating potential in terms of 
anticancerous and antioxidative properties of herbal ethanolic extract of ASVERADO from fruit 
of Persea Americana Mill, leaves of Aloe vera (L.) Burm.f., & Root of Withania Somnifera on 
DMBA induced mammary tumorigenesis in Wistar rats. 
The preliminary phytochemical studies on ASVERADO discovered the presence of various 
phytoconstituents such as alkaloid, carbohydrates, glycosides, steroid, proteins, flavonoids and 
saponin. 
This research was aimed to evaluate the both in-vitro studies using Breast cancer cell line 
(MCF-7) & in-vivo studies based on the ethanolic extract of ASVERADO for its anti-
neoplasttic activity against 7,12-dimethylbenzeneanthracene (DMBA) induced Mammary 
gland carcinoma in female Wistar rats. 
The biochemical parameters like  Blood Sugar level, Hb count,Albumine, RBC count,PCV,    MCV,  
MCH,MCHC,Total count,  Polymorph, Lymphocytes,Eosinophils,Globulin and Total Protein Binding 
values showed  increase  in the ASVERADO treated rats  when to compared to DMBA treated rats. 
The antioxidants defense in the mammary gland tissues were estimated in terms of SOD, CAT, 
LPO and ASVERDO increased the antioxidant levels at respective dose leading to reduce 
oxidative stress. This clearly indicates the potential of the extract to delay the generation of free 
radicals that cause carcinogenesis. 
The histopathology of DMBA treated rats showed increased in tumor cells. Whereas the control 
and ASVERADO treated rats showed normal level of tumor cells. 
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benz[a]anthracene (DMBA) Induced Mammary Gland Carcinoma In Female Wistar Rats 
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CONCLUSION: 
The present study demonstrated that DMBA induced mammary gland carcinoma in Wistar 
rats. Ethanolic extract of ASVERADO from fruit of Persea Americana Mill, leaves of Aloe vera 
(L.) Burm.f., & Root of Withania Somnifera which  helps in suppressing tumor cells. The anti-
oxidant has potential of delaying the generation of free radicals that cause carcinogenesis. 
 
 Further studies are expected on the isolated components of the extract in order to understand 
the exact mechanism of its action and also studies at cellular level changes by more 
sophisticated methods for investigation. 
 
 
134 
 
1. https://www.news-medical.net/health/What-is-Breast-Cancer.aspx 
 
2. "Cancer Fact sheet N°297". World Health Organization. February 2014. 
Archived from the original on 29 December 2010. Retrieved 10 June 2014. 
3. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J 
Clin. 2012;62:10–29. 
4. Holland Chp. 1 
5. Withrow and Macewen‘s Small Animal Clinical Oncology. 4th edn. 
Saunders, Philadelphia pp. xv-xvii. 
6. Chung SS, Vadgama JV. Curcumin and epigallocatechin gallate inhibit the 
cancer stem cell phenotype via down-regulation of STAT3–NFκB 
signaling. Anticancer Res. 2015;35:39–46 
7. Ahmed OM, Ashour MB, Mahmoud AM, Ahmed NA. Preventive effect 
of Spirulina versicolor and Enteromorpha flexuosa ethanolic extracts against 
diethylnitrosamine/benzo(A)pyrene-induced hapatocarcinogencity in rats. J 
Int Acad Res Multidiscipl. 2014;2(6):633–650. 
8. Akhdar H, Legendre C, Aninat C, Morel F. Anticancer drug metabolism: 
chemotherapy resistance and new therapeutic approaches. In: Paxton J, 
editor. Topics on Drug Metabolism. Croatia: InTech Europe University 
Campus STeP Ri; 2012. pp. 137–170. 
9. Gerhauser C, Alt A, Heiss E, et al. Cancer chemopreventive activity of 
xanthohumol, a natural product derived from hop. Mol Cancer Ther. 2002; 
1:959–969. 
10. Anand P, Kunnumakkara AB, Kunnumakara AB, Sundaram C, Harikumar 
KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (September 2008). "Cancer 
is a preventable disease that requires major lifestyle 
changes". Pharmaceutical Research. 25(9): 2097–116. 
135 
 
11. Brawley OW (2004). "Prostate cancer screening: clinical applications and 
challenges". Urol. Oncol. 22 (4): 353–
7. PMID 15283896. doi:10.1016/j.urolonc.2004.04.014 
12. "Cancer kills 1300 Indians every day". Delhi Daily News. Retrieved 2015-
05-17 
13. National Cancer Registry Programme (2013). Three-year report of 
population based cancer registries:2009-2011. NCDIR-ICMR, Bangalore 
14. "Cancer cases on the rise but death rate is falling". The Hindu. 2015-05-29. 
ISSN 0971-751X. Retrieved 2016-02-27. 
15. Jemal A, Siegel R, Ward E, et al. (2008). "Cancer statistics, 2008". CA 
Cancer J Clin. 58 (2): 71–96. PMID 18287387. doi:10.3322/CA.2007.0010 
16. Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR, 
eds. (1999). Cancer Incidence and Survival among Children and 
Adolescents, United States SEER program 1975–1995. Bethesda MD: 
National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. 
17. Knudson AG (November 2001). "Two genetic hits (more or less) to cancer". 
Nature Reviews. Cancer. 1 (2): 157–62. PMID 11905807. 
doi:10.1038/35101031 
18. Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, White E 
(September 2004). "Hypoxia and defective apoptosis drive genomic 
instability and tumorigenesis". Genes & Development. 18 (17): 2095–107. 
PMC 515288  Freely accessible. PMID 15314031. 
doi:10.1101/gad.1204904 
19. http://www.medicinenet.com/cancer/article.htm 
20. Anguiano L, Mayer DK, Piven ML, Rosenstein D (Jul–Aug 2012). "A 
literature review of suicide in cancer patients". Cancer Nursing. 35 (4): E14–
26. PMID 21946906. doi:10.1097/NCC.0b013e31822fc76c 
136 
 
21. O'Dell, edited by Michael D. Stubblefield, Michael W. (2009). Cancer 
rehabilitation principles and practice. New York: Demos Medical. p. 983. 
ISBN 978-1-933864-33-4. 
22. Vickers, A. 2004. Alternative cancer cures: 'unproven' or 'disproven'? CA 
Cancer J. Clin. 54 (2): 110–118. 
23. "World Cancer Report" (PDF). International Agency for Research on 
Cancer. 2008. Archived (PDF) from the original on 20 July 2011. Retrieved 
26 February 2011. 
24. Male Breast Cancer Treatment". National Cancer Institute. 2014. Archived 
from the original on 4 July 2014. Retrieved 29 June 2014. 
25. World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 
1.1. ISBN 92-832-0429-8. 
26. "SEER Stat Fact Sheets: Breast Cancer". NCI. Archived from the original on 
3 July 2014. Retrieved 18 June 2014. 
27. Cancer Survival in England: Patients Diagnosed 2007–2011 and Followed 
up to 2012" (PDF). Office for National Statistics. 29 October 2013. 
Archived (PDF) from the original on 29 November 2014. Retrieved 29 June 
2014. 
28. Simak Ali, Endocrine-responsive breast cancer and strategies for combating 
resistance Nature Reviews Cancer 2, 101-112 (February 2002) | 
doi:10.1038/nrc72 
29. Vorherr H,  Endocrinology of breast cancer , Maturitas. 1987 Aug;9(2):113-
22. 
30. MECHANISMS OF ENDOCRINE RESISTANCE IN BREAST CANCER   
Annu Rev Med. 2011; 62: 233–247. 
31. Klein CA (September 2008). "Cancer. The metastasis cascade". Science. 321 
(5897): 1785–7. PMID 18818347. doi:10.1126/science.1164853.\ 
32. Chiang AC, Massagué J (December 2008). "Molecular basis of metastasis". 
The New England Journal of Medicine. 359 (26): 2814–23. PMC 4189180 
137 
 
33. Casey G, Growth suppression of human breast cancer cells by the 
introduction of a wild-type p53 gene. Oncogene [01 Oct 1991, 6(10):1791-
1797] 
34. JESSICA EVERT, Breast Cancer: Introduction JUN 30, 2010 
35. Sinn, HP; Kreipe, H (May 2013). "A Brief Overview of the WHO 
Classification of Breast Tumors, 4th Edition, Focusing on Issues and 
Updates from the 3rd Edition". Breast care (Basel, Switzerland). 8 (2): 149–
154. doi:10.1159/000350774. 
36. Seltzer, William H. Hindle, editor ; with a foreword by Vicki (1999). Breast 
care: a clinical guidebook for women's primary health care providers. New 
York: Springer. p. 129. ISBN 9780387983486. 
37. Staging, Breastcancer.org 
38. Breast Cancer Treatment (PDQ®)". NCI. 2014-04-11. Retrieved 19 June 
2014. 
39. Pointon KS, Cunningham DA (August 1999). "Ultrasound findings in pure 
invasive lobular carcinoma of the breast: comparison with matched cases of 
invasive ductal carcinoma of the breast". Breast. 8 (4): 188–90. PMID 
14731438. doi:10.1054/brst.1999.0042. 
40. Boughey JC, Wagner J, Garrett BJ, et al. (March 2009). "Neoadjuvant 
Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of 
Breast Conservation". Ann. Surg. Oncol. 16 (6): 1606–11. PMID 19280264. 
doi:10.1245/s10434-009-0402-z. 
41. Inflammatory Breast Cancer: Questions and Answers". National Cancer 
Institute. Retrieved 2006-12-02. 
42. alberg K, Hellborg H, Wärnberg F (September 2008). "Paget's disease of the 
nipple in a population based cohort". Breast Cancer Res. Treat. 111 (2): 
313–9. PMID 17952590. doi:10.1007/s10549-007-9783-5. 
138 
 
43. https://www.google.co.in/search?q=types+of+breast+cancer&source=lnms&
tbm=isch&sa=X&ved=0ahUKEwiYkvf9nNLWAhVBr48KHWGIAhIQ_A
UICigB&biw=1366&bih=637#imgrc=NhxatkLhvjKReM 
44. American Cancer Society (2005). "Breast Cancer Facts & Figures 2005–
2006" (PDF). Archived from the original (PDF) on 13 June 2007. Retrieved 
26 April 2007. 
45. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF 
(October 1999). "A systematic review of genetic polymorphisms and breast 
cancer risk". Cancer Epidemiology, Biomarkers & Prevention. 8 (10): 843–
54. PMID 10548311 
46. Wooster R, Weber BL (June 2003). "Breast and ovarian cancer". N. Engl. J. 
Med. 348(23): 2339–47. PMID 12788999. doi:10.1056/NEJMra012284. 
47. Haslam SZ, Woodward TL (June 2003). "Host microenvironment in breast 
cancer development: epithelial-cell-stromal-cell interactions and steroid 
hormone action in normal and cancerous mammary gland.". Breast Cancer 
Res. 5 (4): 208–15. PMC 165024  Freely accessible. PMID 12817994. 
doi:10.1186/bcr615 
48. Wiseman BS, Werb Z (May 2002). "Stromal effects on mammary gland 
development and breast cancer". Science. 296 (5570): 1046–9. PMC 
2788989. PMID 12004111. doi:10.1126/science.1067431. 
49. https://www.google.co.in/search?biw=1366&bih=637&tbm=isch&sa=1&q=
breast+cancer+pathophysiology+images&oq=breast+cancer+pathophysiolog
y+images&gs_l=psy-
ab.3...74364.85972.0.90393.16.15.1.0.0.0.393.2354.0j1j6j2.9.0.dummy_map
s_web_fallback...0...1.1.64.psy-
ab..6.0.0....0.GRQugTBjnhM#imgrc=C7opwjTIglKV4M: 
50. McGuire, A; Brown, JA; Malone, C; McLaughlin, R; Kerin, MJ (22 May 
2015). "Effects of age on the detection and management of breast cancer.". 
139 
 
Cancers. 7 (2): 908–29. PMC 4491690. PMID 26010605. 
doi:10.3390/cancers7020815. 
51. World Cancer Report". International Agency for Research on Cancer. 
2008. Archived from the original on 31 December 2011. Retrieved 26 
February 2011. (cancer statistics often exclude non-melanoma skin cancers 
such as basal-cell carcinoma, which are common but rarely fatal) 
52. World Cancer Report 2014. International Agency for Research on Cancer, 
World Health Organization. 2014. ISBN 978-92-832-0432-9. 
53. Stewart B. W. and Kleihues P. (Eds): World Cancer Report. IARCPress. 
Lyon 2003 Archived 20 October 2008 at the Wayback Machine. 
54. Breast Cancer: Breast Cancer in Young Women Archived 10 September 
2009 at the Wayback Machine. WebMD. Retrieved 9 September 2009 
55. World Cancer Report". International Agency for Research on Cancer. 2008. 
Archived from the original on 2011-01-14. Retrieved 2011-02-26.(cancer 
statistics often exclude non-melanoma skin cancers such as basal cell 
carcinoma which though very common are rarely fatal) 
56. "Breast cancer: prevention and control". World Health Organization. 
Archived from the original on 2015-09-06. 
57. Breast Cancer: Breast Cancer in Young Women WebMD. Retrieved on 
September 9, 2009 
58. B. W. and Kleihues P. (Eds): World Cancer Report. IARCPress. Lyon 2003 
59. Jemal A, Siegel R, Ward E, et al. (2008). "Cancer statistics, 2008". CA 
Cancer J Clin. 58 (2): 71–96. PMID 18287387. doi:10.3322/CA.2007.0010. 
Archived from the original on 2011-07-03. 
60. Institute of Medicine (2012). Breast Cancer and the Environment: A Life 
Course Approach (Institute of Medicine). Washington, D.C: National 
Academies Press. pp. 52–53. ISBN 0-309-22069-6. 
140 
 
61. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN (1995). 
"Proportion of breast cancer cases in the United States explained by well-
established risk factors". J. Natl. Cancer Inst. 87 (22): 1681–5. PMID 
7473816. doi:10.1093/jnci/87.22.1681. 
62. Olson, James Stuart (2002). Bathsheba's Breast: Women, Cancer and 
History. Baltimore: The Johns Hopkins University Press. pp. 199–200. 
ISBN 0-8018-6936-6. OCLC 186453370. 
63. National Cancer Institute (2006-08-03). "Hormone Therapy". Genetics of 
Breast and Ovarian Cancer. Retrieved 2006-08-12. 
64. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, 
Ostrander EA (1998). "BRCA1 mutations and breast cancer in the general 
population: analyses in women before age 35 years and in women before age 
45 years with first-degree family history". JAMA. 279 (12): 922–9. PMID 
9544766. doi:10.1001/jama.279.12.922. 
65. Margolese, Richard G, Bernard Fisher, Gabriel N Hortobagyi, and William 
D Bloomer (2000). "118". In Bast RC, Kufe DW, Pollock RE, et al. Cancer 
Medicine (e.5 ed.). Hamilton, Ontario: B.C. Decker. ISBN 1-55009-113-1. 
Retrieved 27 January 2011 
66. Collaborative Group on Hormonal Factors in Breast Cancer. (1997). "Breast 
cancer and hormone replacement therapy: collaborative reanalysis of data 
from 51 epidemiological studies of 52,705 women with breast cancer and 
108,411 women without breast cancer". Lancet. 350 (9084): 1047–59. PMID 
10213546. doi:10.1016/S0140-6736(97)08233-0. Retrieved 2008-04-08. 
67. Collaborative Group on Hormonal Factors in Breast Cancer (1996). "Breast 
cancer and hormonal contraceptives: collaborative reanalysis of individual 
data on 53,297 women with breast cancer and 100,239 women without 
breast cancer from 54 epidemiological studies". Lancet. 347 (9017): 1713–
27. PMID 8656904. doi:10.1016/S0140-6736(96)90806-5 
68. http://www.medscape.com/viewarticle/517532 
141 
 
69. World Health Organization International Agency for Research on Cancer 
(1999). "Hormonal Contraception and Post-menopausal Hormonal Therapy" 
(PDF). IARC Monographs on the Evaluation of Carcinogenic Risks to 
Humans. 72. Retrieved 12 March 2011. 
70. Heiss, G.; Wallace, R.; Anderson, G. L.; Aragaki, A.; Beresford, S. A. A.; 
Brzyski, R.; Chlebowski, R. T.; Gass, M.; Lacroix, A. (2008). "Health Risks 
and Benefits 3 Years After Stopping Randomized Treatment with Estrogen 
and Progestin". JAMA: The Journal of the American Medical Association. 
299 (9): 1036–45. PMID 18319414. 
71. Holmes, M.D.; et al. (2005). "Physical activity and survival after breast 
cancer diagnosis". JAMA. 293 (20): 2479–86. 
doi:10.1001/jama.293.20.2479. 
72. Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, 
Clapp RW, Burke KP, Willett WC, MacMahon B. (1994-01-13). "Lactation 
and a reduced risk of premenopausal breast cancer". New England Journal of 
Medicine. 330 (2): 81–7. PMID 8259187. 
doi:10.1056/NEJM199401133300201. 
73. Ligibel, J (2011). "Obesity and Breast Cancer". Oncology. 25 (11): 994–
1000. 
74. Palmer JR, Wise LA, Hatch EE, et al. (August 2006). "Prenatal 
diethylstilbestrol exposure and risk of breast cancer". Cancer Epidemiology, 
Biomarkers & Prevention. 15 (8): 1509–14. PMID 16896041. 
doi:10.1158/1055-9965.EPI-06-0109. 
75. Merck Manual of Diagnosis and Therapy (February 2003). "Breast 
Disorders: Breast Cancer". Archived from the original on 2 October 2011. 
Retrieved 5 February 2008. 
76. Watson M (2008). "Assessment of suspected cancer". InnoAiT. 1 (2): 94–
107. doi:10.1093/innovait/inn001 
142 
 
77. National Cancer Institute (27 June 2005). "Paget's Disease of the Nipple: 
Questions and Answers". Archived from the original on 10 April 2008. 
Retrieved 6 February 2008 
78. Centers for Disease Control and Prevention. Archived from the original on 
18 November 2015. Retrieved 17 November 2015. 
79. "Breast Cancer and Mammograms". WebMD. Archived from the original on 
28 December 2012. Retrieved 24 December 2012. 
80. Burstein, HJ; Temin, S; Anderson, H; Buchholz, TA; Davidson, NE; 
Gelmon, KE; Giordano, SH; Hudis, CA; Rowden, D; Solky, AJ; Stearns, V; 
Winer, EP; Griggs, JJ (27 May 2014). "Adjuvant Endocrine Therapy for 
Women With Hormone Receptor-Positive Breast Cancer: American Society 
of Clinical Oncology Clinical Practice Guideline Focused Update.". Journal 
of Clinical Oncology. 32 (21): 2255–69. PMID 24868023. 
doi:10.1200/JCO.2013.54.2258 
81. Klein, Judith. "Differences in male breast cancer stage, tumor size at 
diagnosis, and survival rate between metropolitan and nonmetropolitan 
regions". Proquest. Archived from the original on 20 May 2013. Retrieved 7 
December 2012. 
82. Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, 
Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye 
L, Piccart-Gebhart MJ, de Azambuja E (August 2011). "Role of the 
multidisciplinary team in breast cancer management: results from a large 
international survey involving 39 countries". Annals of Oncology. 23 (4): 
853–9. PMID 21821551. doi:10.1093/annonc/mdr352 
83. "What Is Mastectomy?". May 16, 2013. Retrieved September 13, 2014. 
84. Halsted, William S. (1894-11-01). "I. The Results of Operations for the Cure 
of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 
1889, to January, 1894". Annals of Surgery. 20 (5): 497–555. ISSN 0003-
143 
 
4932. PMC 1493925. PMID 17860107. doi:10.1097/00000658-189407000-
00075. 
85. Massarut S, Baldassare G, Belleti B, Reccanello S, D'Andrea S, Ezio C, 
Perin T, Roncadin M, Vaidya JS (2006). "Intraoperative radiotherapy 
impairs breast cancer cell motility induced by surgical wound fluid". J Clin 
Oncol. 24 (18S): 10611. Archived from the original on 12 January 2012. 
86. "Radiation Therapy". Breastcancer.org. Archived from the original on 17 
November 2015. Retrieved 17 November 2015. 
87. Rachel Airley (2009). Cancer chemotherapy. Wiley-Blackwell. ISBN 0-470-
09254-8 
88. Medicinal Plants: Their Use in Anticancer Treatment M. Greenwell and 
P.K.S.M. Rahman, Int J Pharm Sci Res. 2015 Oct 1; 6(10): 4103–4112. doi:  
10.13040/IJPSR.0975-8232.6(10).4103-12 
89. Kaur, R., Kapoor, K. and Kaur, H. 2011. Plants as a source of anticancer 
agents. J. Nat. Prod. Plant Resour. 1(1): 119 – 124. 
90. http://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:325643-
2#descriptions 
91. https://en.wikipedia.org/wiki/Avocado#Botany 
92. https://www.google.co.in/search?biw=1366&bih=638&tbm=isch&sa=1&btn
G=Search&q=images+of+avocado+fruit%2Cleaves%2Cflower#imgrc 
93. https://en.wikipedia.org/wiki/Aloe_vera 
94. ALOE VERA: A SHORT REVIEW Amar Surjushe, Resham Vasani, and D 
G Saple Indian J Dermatol. 2008; 53(4): 163–166. doi:  10.4103/0019-
5154.44785 
95. https://en.wikipedia.org/wiki/Withania_somnifera 
96. http://www.webmd.com/vitamins-supplements/ingredientmono-953-
ashwagandha.aspx?activeingredientid=953 
144 
 
97. https://en.wikipedia.org/wiki/Withania_somnifera 
98. Animal models and therapeutic molecular targets of cancer: utility and 
limitations Maria Cekanova and Kusum Rathore, Drug Des Devel Ther. 
2014; 8: 1911–1922. 
99. Drug Screening Method by S.K.Gupta 
100. Russo, J. and Russo, I.H. 1996. Experimentally induced mammary 
tumors in rats. Breast Cancer Res. Treat. 39: 7 – 20. 
101. Miyata M, Furukawa M, Takahashi K, Gonzalez FJ, Yamazoe Y 2001. 
"Mechanism of 7, 12-Dimethylbenz[a]anthracene-Induced Immunotoxicity: 
Role of Metabolic Activation at the Target Organ". Jpn J Pharmacol 86: 
302–309. 
102. Savas, U., Carstens, C.P. and Jefcoate, C.R. 1997. Biological oxidations 
and P450 reactions. Recombinant mouse CYP1B1 expressed in Escherichia 
coli exhibits selective binding by polycyclic hydrocarbons and metabolism 
which parallels C3H10T1/2 cell microsomes, but differs from human 
recombinant CYP1B1. Arch. Biochem. Biophys., 347, 181–192. 
103. Buters, J.T.M., Sakai, S., Richter, T., Pineau, T., Alexander, D.L., Savas, 
U., Doehmer, J., Ward, J., Jefcoate, C.R. and Gonzalez, F.J. 1999. 
Cytochrome P450 CYP1B1 determines susceptibility to 7,12-
dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl Acad. Sci. USA, 
96,1977–1982. 
104. Mosmann, 1983, MTT assay procedure. 
105. Purabi Roy, Sarika Ambedkar, Avnish Kumar and Vinod Singh. 
Preliminary study of the properties of flowers and roots of Pyrostegiavenusta 
(Ker Gawl) Miers BMC Complementary and Alternative Medicine 
2011;11;69 
145 
 
106. Ecobichon DJ. The basis of Toxicity testing, 2nd Edition, CRC press, 
New York, 1997; 43-88. 
107. Miyata M; Furukawa M; Takahashi K; Gonzalez FJ; Yamazoe Y (2001). 
"Mechanism of 7, 12-Dimethylbenz[a]anthracene-Induced Immunotoxicity: 
Role of Metabolic Activation at the Target Organ". Jpn J Pharmacol. 86: 
302–309. doi:10.1254/jjp.86.302. 
108. Sung YM; He G; Fischer, SM (2005). "Lack of Expression of the EP2 but 
not EP3 Receptor for Prostaglandin E2 Results in Suppression of Skin 
Tumor Development". Cancer Res. 65: 9304–9311. doi:10.1158/0008-
5472.can-05-1015 
109. Friedenson B (August 2007). "The BRCA1/2 pathway prevents 
hematologic cancers in addition to breast and ovarian cancers". BMC 
Cancer. 7: 152–162. PMC 1959234 . PMID 17683622. doi:10.1186/1471-
2407-7-152. 
110. Friedenson B (2008-06-08). "Breast cancer genes protect against some 
leukemias and lymphomas" (video). SciVee. 
111. "Breast and Ovarian Cancer Genetic Screening". Palo Alto Medical 
Foundation. Archived from the original on 4 October 2008. Retrieved 2008-
10-11. 
112. Friedenson B (2007). "The BRCA1/2 pathway prevents hematologic 
cancers in addition to breast and ovarian cancers". BMC Cancer. 7: 
152. PMC 1959234 . PMID 17683622. doi:10.1186/1471-2407-7-152. 
113. O'Donovan PJ, Livingston DM (April 2010). "BRCA1 and BRCA2: 
breast/ovarian cancer susceptibility gene products and participants in DNA 
double-strand break repair". Carcinogenesis. 31 (6): 961–
7. PMID 20400477. doi:10.1093/carcin/bgq069 
 
 
 
 
 
146 
 
ANNEXURE 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
147 
 
ANNEXURE 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
148 
 
ANNEXURE 3 
 
 
 
 
 
 
 
 
 
 
 
